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ABSTRACT
This dissertation research explored mechanisms of human milk
(HM) expulsion by describing the effects of skin to skin contact
(SSC) on maternal basal oxytocin (OT) secretion among 20
premature mothers with hospitalized premature infants. This onegroup, repeated measures design consisted of: 1) daily SSC with
covariant data via self-report diary and 2) maternal salivary OT
with and without SSC at 4 time points were collected over a 7
day time frame. Results indicate that mean levels of basal OT
increase over time (M 234 pg/ml, SD 108 pg/ml time point 1; M
257 pg/ml, SD 125 pg/ml time point 3). Through multilevel model
data analysis basal OT was found to have a meaningful amount of
dependence on SSC frequency (t(16) = 6.389, p = < 0.001) and SSC
duration (t(17) = 6.867, p = < 0.001) with coefficient estimates
that indicate that basal OT exposed to 75-85 minutes of SSC per
day are 92 pg/ml higher. These findings provide preliminary data
that suggest that lactating mothers with premature infants
sustain positive effects of SSC that increase basal OT secretion
over time.

viii

CHAPTER ONE:
INTRODUCTION

Introduction to the Problem
Infant mortality among the 3.6 million infant deaths
reported by the World Health Organization (Robert et al., 2010)
occurred within the first 28 days of life with nearly 50% within
the first 24 hours relative to prematurity, infections and
asphyxia. In the United States, medical advancements in neonatal
resuscitation have improved survival rates of infants at birth.
However, prematurity remains one of the top three leading causes
of death annually (Mathew & MacDorman, 2011). Of the surviving
premature infants, many are at high risk for comorbidities, such
as necrotizing enterocolitis (NEC), sepsis, and impaired neurocognitive development (Gartner et al., 2005). Immediate
postnatal care with an emphasis on neonatal warmth and early
initiation of breastfeeding are effective interventions that
reduce infant mortality and prevent co-morbidities of
prematurity (Robert et al., 2010; Ganapathy, Hay, & Kim, 2012;
Meier, Engstrom, Patel, Jegier, & Bruns, 2010). Compared to
1

conventional incubator care, skin to skin contact (SSC) equally
stabilizes neonatal warmth and thermoregulation (Bystrova et
al., 2003). However, SSC is more effective in positive
breastfeeding outcomes (Aghdas, Talat, & Sepideh, 2013; Hurst,
Valentine, Renfro, Burns, & Ferlic, 1997).

Statement of the Problem
Despite the evidence that supports the benefits of SSC and
breastfeeding, SSC is seldom practiced in western cultures
(Moore, Anderson, Bergman & Dowswell, 2012). In addition,
breastfeeding rates for postpartum mothers of premature infants
are statistically lower than women who birth healthy term
infants. Mothers of premature infants who successfully initiate
breastfeeding are less likely to sustain breastfeeding until
neonatal discharge because of low human milk volume (Spatz,
2004; Zanardo et al., 2011).
Mechanisms that impact human milk volume are complex, with
bio-behavioral underpinnings. Immediately after delivery,
mothers with premature infants are often physically challenged
by pregnancy complications, trauma associated with preterm
delivery, and mentally challenged by barriers in privacy,
overall concern for their infants’ health and emotional distress
secondary to grief, loss or separation (Sisk, Quandt, Parson, &
Tucker, 2010; Shah, Clements & Poehlmann, 2011). These
2

compounding circumstances often induce additional psychological
stressors that manifest maternal feelings of fatigue, anxiety,
stress or even depression (Obeidat, Bond, & Callister, 2009;
Morelius, Theodorsson, & Nelson, 2005; Flacking, 2007; Sisk et
al., 2010; Shah et al., 2011). Physiologically, such biobehavioral stressors negatively affect the physiology of human
milk synthesis by inhibiting the secretion of lactogenic
hormones necessary to stimulate lactogenesis (i.e. human milk
synthesis)(Buhimschi, 2004; Dewey, 2001; Bruckmaier & Wellnitz,
2008; Ueda, Yokoyama, Irahara & Aono, 1994; Newton, M. & Newton,
N. R.,1948).
During lactogenesis, oxytocin is an important hormone
responsible for galactokinesis, a process in which human milk is
ejected from the mammary gland (Buhimschi, 2004). A poor
ejection reflex due to insufficient oxytocin secretion
perpetuates a cycle that negatively affects the amount of human
milk expelled from the mammary glands. This in turn leads to
lactation failure due to inadequate human milk volume
(Buhimschi, 2004).
An increase in oxytocin secretion can be triggered in
response to non-noxious stimuli such as touch or massage among
animal subjects (Uvnas-Moberg, 1996). Similarly, tactile
stimulation via infant holding has been shown to enhance
oxytocin secretion among lactating mothers of full term human
3

infants (Ueda et al., 1994). Additionally, tactile stimulation
via direct SSC has been shown to positively influence human milk
volume among mothers with preterm infants (Hurst, 2007; Hill et
al., 2009). Conceivably, SSC can be an effective method that
enhances both oxytocin secretion and human milk volume. However,
the true clinical significance of the relationship between SSC
and basal oxytocin levels on human milk volume have yet to be
determined.
Purpose of the Study
The purpose of this research is to explore mechanisms of
galactokinesis by analyzing the effects of SSC on maternal
oxytocin basal salivary levels among lactating mothers with
hospitalized premature infants. Findings from this research are
expected to inform the long term research goal of a program of
research on biobehavioral mechanisms of SSC on human lactation
and maternal psychological health.

Specific Aims
The aims of this study are:
Aim 1: Explore the relationship between basal salivary oxytocin
levels and amount of skin to skin contact (SSC) among lactating
mothers with hospitalized premature infants.
Research Questions:
4

1a. Does maternal basal salivary oxytocin differ across 7
days in mothers before SSC?
1b. Does SSC frequency affect basal salivary oxytocin
levels?
1c. Does SSC duration affect basal salivary oxytocin
levels?

Definition of Relevant Terms
Skin to Skin Contact (SSC) occurs when a naked neonate is
placed prone on his/her mother’s bare chest (Moore et al.,
2012). The use of early SSC immediate post birth has been known
to reduce infant mortality (Lawn, Mwansa-Kambafwile, Horta,
Barros, & Cousens, 2010). Beyond the first hour of birth,
intermittent and continuous SSC among premature infants
regulates neonatal oxygen saturation, heart rate, breathing,
glucose and assists transitioning neonates to breastfeed
(Bergman, Linley, & Fawcus, 2004; Nyqvist et al., 2010).
Lactogenesis is a two stage process of human milk synthesis
(Hurst, 2007). Stage I represents the onset of human milk
synthesis initiated during the second trimester of pregnancy.
Once the placenta is expelled after birth, progesterone levels
decline rapidly and prolactin is secreted (Buhimschi, 2004;
Nedkova & Tanchev, 1995). Within four days postpartum,
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increasing prolactin levels then trigger the beginning of
copious milk synthesis known as lactogenesis II (Hurst, 2007).
Oxytocin is a nine amino acid neuropeptide secreted from the
posterior pituitary gland responsible for uterine contractility
at birth and human milk ejection during lactation (Gabor, 2012).
More recent studies among the social sciences have linked oxytocin
as an important biomarker that facilitates parental affiliation
and stress modulation within animal and human subjects (Feldman,
Gordon, & Zagoory-Sharon, 2011. Synchronous maternal-infant
behaviors found in these studies implicates that mothers who
provide more affectionate tactile contact have an increase in
oxytocin release following maternal-child interaction.
Galactokinesis is the process in which human milk is
ejected from the mammary gland (Buhimschi, 2004). During
breastfeeding, nerve impulses generated from areolar stimulation
via massage and suckling activate the central nervous system to
elicit the pulsatile release of oxytocin from the posterior
pituitary (Matthiesen, Ransjö-Arvidson, Nissen, & Uvnäs-Moberg,
2001; Ueda, Yokoyama, Irahara, & Aono, 1994). Excreted oxytocin
is then carried through the blood stream to the mammary gland,
where oxytocin finally attaches to epithelial cell receptors
located on milk-secreting alveoli in the milk ducts. This causes
the milk duct cells to contract, resulting in expulsion of milk
from the mammary gland (Hurst, 2007).
6

Assumptions
Mothers with premature infants in the neonatal intensive
care unit experience stressors that trigger episodes of
depression, anxiety (Carvalho, Linhares, Padovani, & Martinez,
2009; Padovani, Linhares, Pinto, Duarte, & Martinez, 2008;
Ukpong, Fatoye, Oseni, & Adewuya, 2003) and elevated cortisol
levels. Over time, the recurrent practice of SSC intervention
has been shown to reduce maternal cortisol levels by 32%
(Morelius et al., 2005). This evidence suggests that SSC can be
considered a behavior that down regulates psychological stress
responses. However, due to the complexity of such a phenomenon,
inclusion of stress as a dependent variable is beyond the scope
of this research and will not be measured. Nonetheless based on
the SSC research discussed earlier by Morelius et al. (2005) it
is assumed that post-partum mothers of premature infants are
experiencing a high stress state prior to SSC intervention.

Significance
This study has a high level of significance for nursing
science because it explores a new biomarker that will aid in
describing the relationship between SSC and secretion of
oxytocin lactogenic hormone. Secretion of oxytocin has been
known to elicit maternal “feel good” responses that improve
7

maternal mood (Samuel et al., 2015). A new understanding of the
relationship of SSC and basal oxytocin level is expected to
emerge that adds to the understanding of the physiology of
galactokinesis or human milk expulsion. These finding may
indirectly explain how to sustain exclusive human milk feedings
for premature infants. Immunologic benefits of breast milk,
consumed by the premature infant via exclusive human milk
feedings offers a significant contribution to neonatal health
care outcomes by reducing the incidences of neonatal
complications associated with premature delivery, such as
sepsis, NEC, and death.
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CHAPTER TWO:
LITERATURE REVIEW

Objective
The objective of this chapter is to review and critique
scientific evidence that supports current knowledge of skin to
skin contact, oxytocin and human milk volume. First, an
introduction to the topic with reference to breastfeeding rates
among premature infants will provide data that supports the
significance of the problem. Next, linkages between maternalinfant factors that contribute to insufficient human milk volume
will be summarized based on an evidence based schematic.
Additional biobehavioral factors that influence insufficient
human milk volume will be further discussed to emphasize the
compounding effects of the maternal-infant relationship on human
milk synthesis. Physiologic effects of compounding factors among
lactating women will be further analyzed to understand maternal
stress responses that may inhibit lactogenesis and
galactokinesis. Mediating effects of skin to skin contact (SSC)
will be presented as a means to deregulate maternal stress
responses in order to influence oxytocin and galactokinesis.
13

Concluding remarks will provide a summary that identifies gaps
in the literature requiring further research and present a logic
model that aims to fill the gaps by exploring the relationship
between basal salivary oxytocin levels and SSC.
Literature considered for this review was extracted from
PubMed, CINAHL and Web of Science databases utilizing a
combination of keywords with “skin to skin contact”, “kangaroo
care”, “breastfeeding”, “human milk volume”, “prematurity” and
“oxytocin”. Three-hundred and ten abstracts were retrieved and
reviewed for content.

After excluding systematic reviews, print

duplications, irrelevant literature and animal model designs, 31
studies were included for review.

Human Milk Feedings and Premature Infants
The American Academy of Pediatrics (2012) recommends
exclusive breastfeeding for the first six month of life as the
gold standard of nutrition for all newborns, including premature
infants. Nutritional benefits of exclusive human milk feedings
support optimal growth and development, while immunologic
components reduce risks of necrotizing enterocolitis, sepsis and
death (Gartner et al., 2011; Patel et al., 2013). Statistically,
breastfeeding initiation rates for postpartum mothers of
premature infants are significantly lower than women who birth
healthy term infants and fewer than 50% of these mothers sustain
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breastfeeding until neonatal discharge due to insufficient human
milk volume (less than 500 milliliters per 24 hours 7-10 days
post-partum) (Hill & Aldag, 2005; Hill, Aldag, & Chatterton,
1999; Spatz, 2004).
Insufficient human milk volume was identified as one of the
leading causes for breastfeeding cessation by the Centers for
Disease Control and Prevention (Li, Fein, Chen, & GrummerStrawn, 2008) among 1,323 lactating mothers of full-term or late
preterm infants weighing at least 5 pounds at birth. Self-report
questionnaires completed by participants queried whether or not
mothers had stopped breastfeeding or pumping for her infant.
Those who answered yes were then asked to rate the importance of
32 reasons for breastfeeding cessation on a 4-point Likert scale
ranging from not important to very important. The top seven
factors that accounted for 54% of the motives for breastfeeding
cessation included: (1) lactation issues related to latch-on or
nipple/breast problems, (2) psychosocial reasons related to
breastfeeding attitudes and social support, (3) nutritional
concerns about milk supply, (4) lifestyle issues related to
diet, smoking, and autonomy, (5) medical reasons related to the
mother's or infant's illness, (6) milk pumping concerns related
to mothers willingness or accessibility to express breast milk,
and (7) self-weaning issues related to biting or losing
interest. Regardless of the weaning age, the most consistent
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reason for breastfeeding cessation of the top seven factors
among 43-55% of all participants included perceptions of
insufficient milk supply.

Insufficient Human Milk Volume Schematic
Dewey (2001) links perceptions of insufficient milk supply
to biologic and behavioral stressors that influence the
physiology of human milk synthesis in a schematic that
identifies two causative pathways that influence insufficient
human milk volume related to the birthing process. The first
pathway originates with mode of delivery (e.g. vaginal vs.
cesarean birth), while the second originates with medications
necessary for birth (e.g. epidurals). Conceptually, adverse
birthing outcomes that influence the mode of delivery also
influence medications necessary for birth, likewise, medications
that are not tolerated by the fetus during the labor influence
the mode of delivery. Secondary stressors that are precipitated
by mode of delivery and medications include duration/difficulty
of labor and infant suck reflex. In response to these stressors,
human milk production is compromised because of a delay in
breastfeeding onset or nipple stimulation. Effects of a
suppressed suckle-induced hormone response lead to insufficient
human milk volume until mechanisms of human milk synthesis
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(lactogenesis) and human milk ejection (galactokinesis) are
restored.
In addition to these pathways, Dewey (2001) further
describes how the reciprocal nature of maternal-infant
breastfeeding relationship inversely influences human milk
volume. For example, early gestational age impacts the infant’s
suckling behavior at the breast. Ineffective suckling of the
breast can trigger a delayed onset of milk synthesis which can
inversely cause the mother to be stressed resulting in
insufficient human milk volume. These compounding effects can
negatively affect the physiology of lactogenesis and
galactokinesis (Table 1).
McNeilly, Robinson, Houston, and Howie (1983) measured
physiologic effects of infant suckling behavior in a small
sample. One group included five women in early stages of
lactogenesis and the second group included five women in later
stages of lactogenesis. Among all women, oxytocin was found to
be released in a pulsatile manner during suckling with higher
concentrations three to 10 minutes before suckling began.
Stimuli that triggered the release of oxytocin were in response
to the baby crying (n=5), the baby becoming restless in
expectation of the feed (n=3) and as the mother prepared for the
feeding (n=2).

Stimulation of the nipple during suckling was

the only stimuli that solicited prolactin release. These results
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indicate milk ejection reflex, with release of oxytocin, occurs
in most women before the tactile stimulus of suckling with a
second release of oxytocin in response to the suckling stimuli
itself. Implications of the study indicate that lack of suckling
stimulation or ineffective suckling behavior can delay the
release of lactogenic hormone and result in a poor milk ejection
reflex. Results also implicate that breastfeeding mothers should
be protected from stress during suckling and immediately before
nipple stimulation, when a conditioned release of oxytocin is
expected to occur to prevent the inhibition of oxytocin
secretion (McNeilly et al., 1983).

Additional Factors that Influence Human Milk Synthesis & Volume
Multiple maternal-infant factors influence human milk
synthesis (Table 2). Biologic factors that adversely affect the
physiology of human synthesis and ejection reflex include:
parity, mode of delivery, body mass index, comorbidities,
smoking, medications, breast anatomy, stress, anxiety, infant
gestational age and weight (Fuertes, Santos, Beeghly, & Tronick,
2006; Gizzo et al., 2012; Handlin et al., 2012; Hill et al.,
1999). Behavioral factors that indirectly impact human milk
synthesis include: maternal self-efficacy and motivation to
breastfeed, nursing frequency, method of nipple stimulation, use
of supplements or pacifiers, social support and infant
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temperament (Acuna-Muga et al., 2014; Hill & Aldag, 2005; Hill
et al., 1999; Keemer, 2013; Riordan, Woodley, & Heaton, 1994).
Psychosocial constructs and social determinants also highly
impact breastfeeding duration in addition to maternal perception
of human milk volume (Li, Fein, Chen, & Grummer-Strawn, 2008).
Hispanics and mothers with household incomes significantly lower
than the federal poverty level are most likely to stop
breastfeeding prematurely.

Other social determinants include

maternal demographics like women of younger age, unmarried,
primiparous, lower education, enrollment in government women
infant and children nutrition programs (WIC) programs, and a
resident of the Midwest or the South (Li, Fein, Chen, & GrummerStrawn, 2008).

Physiologic Effects of Biobehavioral Factors that Influence
Human Milk Synthesis & Volume
As mentioned in Dewey’s (2001) schematic, compounding
effects of biobehavioral factors related to the maternal-infant
breastfeeding relationship induce psychologic stress responses.
Zanardo et al. (2011) addressed psychological distress on
lactation performance in mothers with late preterm infants. This
study enrolled 42 mothers with singleton infants born 34-36
weeks gestation. After consent, participants completed a selfreport survey identifying select socio-demographics, feeding
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preference, psychosocial care, pre and post pregnancy. Each
participant was interviewed for 30 minutes 3-4 days postpartum
to complete three validated questionnaires: (1) State-Trait
Anxiety Inventory (STAI), (2) the Edinburgh Postnatal Depression
Scale (EPDS) and (3) the Psychological Stress Measure. Data
analysis revealed that mothers who delivered late preterm
infants had significantly lower breastfeeding rates had
significantly higher levels of depression, stress, and anxiety
compared to mothers of term infants. While this data helped
identify that psychological stressors induced by physiologic
(pain) or emotional (anxiety) measures negatively affected
breastfeeding, the inclusion of lactogenic biomarkers limits the
knowledge gained about the relationship of psychologic stressors
on lactogenic hormone secretion, human milk synthesis and
perhaps human milk volume.
Animal model research designs were the first to identify
that hypothalamic-pituitary axis (HPA) reactivity to physical
and emotional stressors were lessened during lactation (Neumann
et al., 1998). Tu, Lupien and Walker (2006) tested this
hypothesis among human subjects by investigating HPA
responsiveness related to feeding methods and psychological
stressors among human subjects. Sixty-six women enrolled were in
between 5-20 weeks postpartum. Participants were asked to
participate in two stress exposure sessions. One was the
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standard Trier Social Stress Test and the other an emotional
video evoking threats to children. Participants that were
breastfeeding ended up with reduced responsiveness to the Trier
Social Stress Test and child-related stressors. Tu and Lupien
(2006) hypothesized that such findings may indicate that changes
in neural mechanisms that modulate the HPA axis during pregnancy
and lactation desensitize stress circuits, thus reducing the
overall stress induced cortisol secretion.
Groer and Davis (2006) concur with the desensitization and
down-regulated HPA stress response phenomenon, but perceived the
phenomenon as a protective measure in lactating women. This was
evidenced by their cross sectional study that compared mothers
exclusively breastfeeding verses formula feeding. Among formula
feeding mothers, biomarkers (serum levels of interferon-gamma
and interleukin-10) were decreased in addition to elevated
perceived stress, mood and negative life experience.
Given that lactogenic hormone secretion (oxytocin) depends
on the activation of the HPA, it is possible that
desensitization may negatively affect lactogenic hormone
secretion from the posterior pituitary gland. As early as 1948,
Newton and Newton identified inhibitory effects of lactogenic
hormone secretion in response to acute stressful stimuli. Ueda
et al.(1994) evaluated implications of acute stress among 22
exclusively breastfeeding women. Participants were assigned to
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one of three groups categorized on external stress exposure.
Group 1 was the control group in which there was no external
stress exposure, group 2 was the mental stress group in which
participants were exposed to cognitive stressors of verbal math
problem calculations, and group 3 was the noise stress group in
which participants were exposed to sounds of building
construction at a mean of 70 decibels.

Serum oxytocin samples

were collected every 2 minutes before and after breastfeeding
and during measuring milk transfer pre and post weights.
Frequency of pulsatile release of oxytocin was significantly
lower in both stress exposed groups. These findings support the
hypothesis that stress negatively affects lactogenesis by
inhibiting oxytocin release during galactokinesis. Further
applications of Ueda et al.’s (1994) findings speculate that
suckling induced oxytocin release may be regulated by the
central nervous system; indicating that psychological relaxation
may be essential for an adequate milk ejection let-down
response.

Mediating Effects of Skin to Skin Contact on Stress Responses
SSC has been known to promote psychological relaxation by
mediating stress and anxiety through attachment and bonding
behaviors (Dalbye, Calais, & Berg, 2011; Tessier et al., 1998).
In response to stressful stimuli, Heinrichs et al. (2001)
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enrolled forty-three lactating women. Prior to stress exposure
one group was asked to breastfeed and the other to solely hold
their infants for a 15 minute period. Thirty minutes prior the
intervention, participants were exposed to a brief psychological
stress test measuring anxiety, known as the Trier Social Stress
Test. In this procedure, participants were asked to perform or
speak in front of a panel and then asked to verbally answer a
mathematical question. Salivary or serum cortisol levels were
collected pre, post and during the stress test respectively. No
differences in baseline cortisol levels were identified between
the groups before the stress test. In response to stress
exposure, adrenocorticotropic hormone, total plasma cortisol,
salivary free cortisol, norepinephrine, and epinephrine were
significantly increased in all lactating women (p < 0.001).
However, total plasma cortisol and salivary free cortisol
responses to stress were less among breastfeeding women (p =
0.001 and p = 0.067). Additionally, both breastfeeding and
holding interventions led to decreased anxiety (p < 0.05),
whereas, stress exposure worsened psychologic symptoms of mood,
calmness, and anxiety in total (p < 0.001). Researchers
concluded that breastfeeding and tactile stimulation via holding
interventions may be further explored as effective mechanisms
applicable for reducing psychological stressors.
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Among premature infants, SSC mediates neonatal stress
responses up to 6 hours post extra-uterine life by stabilizing
cardiopulmonary function (Bergman, Linley, & Fawcus, 2004). SSC
also mediates breastfeeding outcomes by facilitating priming of
the olfactory neuro-pathway (Winberg & Porter, 1998). Like other
mammals, newborns exhibit primitive innate reflexes to selfattach to their mother’s nipple. Immediately after birth,
newborns take up to 60 minutes to go through nine phases that
lead them to self-attach to the breast (Widstrom et al., 2011).
Cognitively, preterm infants may not have the capacity to selfattach to the breast but are able to gradually transition to
breastfeed with the practice of SSC intervention (Spatz, 2004).
SSC position gives neonates the opportunity to smell the scent
of their mother’s milk due to the close proximity to the breast.
Breast odors from the mother exert a pheromone-like effect where
the newborn learns to recognize their own mother's unique odor
and locate the mother’s nipple to initiate breastfeeding (Winberg
& Porter, 1998). By the time premature infants are ready to be
discharged home, premature infants exposed to SSC repeatedly
verses infants exposed to conventional incubator care with SSC
are more likely to receive exclusive breastmilk feedings
(Ghavane et al., 2012). However, due to multiple confounders
(neonatal environments, maternal-infant separation, gestation
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age, breast pumping frequency, etc) further correlative studies
are warranted to fully understand how and why SSC promotes
positive breastfeeding outcomes. Further understanding of the
relationship of oxytocin secretion and SSC frequency and
duration is expected to add to this knowledge.

Oxytocin and Skin to Skin Contact
Research synthesized by Kerstin Uvnas-Moberg (1998)
suggests that oxytocin plays a role in positive social
interaction, stress regulation and neuroendocrine functionality
necessary for motherhood and lactation. In this framework
positive social interactions between the mother and the newborn
are expected to begin immediately after birth where the mother
is expected to provide milk, warmth, and protection of her
offspring. During this early period of social interaction,
oxytocin performs two functions. First it allows for milk to be
ejected in response to non-noxious stimuli like infantile
suckling. Second it transmits warmth to her young by
vasodilating blood vessels in the skin that overlay the mammary
gland (Uvnäs-Moberg, 1996). Reciprocal effects of infant social
behaviors like breastfeeding and SSC activate maternal touch and
smell somatosensory afferents that promote antistress effects
that reduce blood pressure (Handlin et al., 2012)and cortisol
(Handlin et al., 2009)and promote sedative effects that solicit
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a calm mood and less anxiety (Nissen, Gustavsson, Widstrom, &
Uvnas-Moberg, 1998; Uvnas-Moberg, 1998b). Physiologically,
Uvnas-Moberg supports oxytocin’s antistress and sedative
properties by emphasizing that the hormone is produced in the
supraoptic (SON) and paraventricular (PVN) nuclei of the
hypothalamus. When triggered, oxytocin is released into
circulation from PVN neurons found in the pituitary. Beyond the
HPA, PVN neurons extend to many other areas like the limbic
system, vagal motor and sensory nuclei, spinal cord and
preganglionic sympathetic neurons. Receptors that enable
oxytocin to act have been found in the uterus with effects that
activate the central nervous system (Uvnäs-Moberg, 1996). This
allows oxytocin to have multiple functions beyond milk ejection,
like stress modulation.
As mentioned previously, antistress effects (Uvnas-Moberg,
1998a)that result in positive mood and decreased anxiety have
also been found among mothers with premature infants through
tactile stimulation (Ahn, Lee, & Shin, 2010; Holditch-Davis et
al., 2014). Additionally, reciprocal effects of maternal-infant
behaviors like SSC positively influence human milk volume and
lactation (Acuna-Muga et al., 2014; Chatterton et al., 2000;
Heidarzadeh, Hosseini, Ershadmanesh, Gholamitabar Tabari, &
Khazaee, 2013). To evaluate effects of SSC on human milk volume,
Hurst et al. (1997) conducted a retrospective chart review
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comparing 24 hour milk volumes of mothers of ventilated low
birth weight infants compared to mothers without SSC
intervention. Mean 24 hour milk volumes at 2, 3, and 4 weeks
after delivery were compared with those of a retrospective
control group from the 12 month period immediately preceding the
introduction of SSC in the neonatal intensive care unit. Data
analysis revealed a strong linear increase in milk volume in the
SSC group compared to no change in milk volume in the control
group.
These findings speculate that skin to skin contact and
oxytocin release are positively correlated. Similarly, oxytocin
is thought to be positively correlated with human milk volume
because it is essential for the expulsion of human milk from the
mammary gland in lactating mothers. While it may be safe to
assume that SSC positively correlates with human milk volume,
dose responses of human milk volume relative to SSC frequency,
duration and oxytocin release have yet to be determined.
Restrictions for measuring plasma oxytocin levels require the
use of multiple invasive blood draws or an indwelling line due
to its pulsatile nature. To circumvent these constraints, the
use of salivary oxytocin has recently gained popularity (HorvatGordon, Granger, Schwartz, Nelson, & Kivlighan, 2005). Further
exploration of basal salivary oxytocin will contribute to the
reliability of salivary oxytocin in research and enhance the
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knowledge of biobehavioral science associated with oxytocin
secretion and SSC.

Summary
Mothers of premature infants experience immediate maternalinfant separation, delayed onset of breastfeeding, poor suckling
and biologic effects of maternal stress and anxiety. Compounding
effects of these stressors inhibit the secretion of oxytocin and
affect the ejection reflex. A poor ejection reflex perpetuates a
cycle that negatively affects the amount of human milk expelled
from the mammary glands. This in turn leads to altered human
milk synthesis and insufficient human milk volume.
Mediating interventions aimed to repair human milk
synthesis and galactokinesis like skin to skin contact is
suspected to ameliorate maternal psychological stress responses
and improve the amount of oxytocin secreted yielding more milk
ejected from the mammary gland. However, the true relationship
between SSC and basal oxytocin levels have yet to be determined
to fully understand the clinical significance of SSC on human
milk volume. The proposed logic model (Figure 1) aims to fill
this gap by determining how SSC frequency and duration influence
basal oxytocin and other co-variants like human milk volume
under similar conditions.
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Table 1.Physiology of Lactogenesis and Galactokinesis
Mechanism

Process

Trigger

Physiology

Lactogenesis

Lactogenesis is a
two stage process

Infant
Suckling

After birth, the
placenta is expelled and
progesterone levels
decline rapidly. This
abrupt withdrawal of
progesterone removes the
inhibitory effect of
progesterone and
triggers lactogenesis in
the presence of high
plasma concentrations of
prolactin secreted from
the anterior pituitary

Infant
Suckling

In response to infant
suckling, impulses from
sensory stimulation of
nerve terminals in the
areola travel to the
central nervous system
triggering a pulsatile
release of oxytocin from
the posterior pituitary

Stage I - The
onset of human
milk synthesis
during the second
trimester of
pregnancy.
Stage II - Within
four days
postpartum,
increasing
prolactin levels
result in copious
milk synthesis
Galactokinesis

Galactokinesis is
a process
responsible for
the ejection of
human milk from
the mammary gland

Conditioned
Responses
like infant
crying prior
breastfeeding
Breast
massage

Oxytocin is then carried
through the blood stream
to the mammary gland
where it interacts with
specific receptors on
the epithelial cells.
Oxytocin binds to
receptors located on
milk-secreting alveoli
in the ducts, initiating
contraction of the
cells, which resulting
in expulsion of milk
from the gland
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Table 2. Biobehavioral Factors that Influence Human Milk Volume
Psychologic

Physiologic

Behavioral

Grief

Mode of Delivery

Bond/Attachment

Anxiety
Fatigue
Stress

Delivery Trauma
Comorbidities
Endocrine
Deficiency
Medications

Nipple Stimulation
Feeding Frequency
Motivation

Hemodynamic
Status
Cardiac Disease

Infant Temperament
Formula
Supplementation
Pacifier Usage

Separation
Pain

Social Support

Biologic
Gestational
Age
Maternal Age
Parity
Body Mass
Index
Breast
Anatomy
Suckle Reflex

*(WIC) Women Infant and Children Government Nutrition Program
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Social
Determinants
Race
Economic Status
WIC* Participant
Transportation
Education Level
Marital Status

Figure 1. Logic Model: Salivary Oxytocin and Skin to Skin
Contact among Lactating Mothers of Premature Infants Model
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CHAPTER THREE:
METHODS

Design
This descriptive, repeated measures design explored the
relationship between basal salivary oxytocin and SSC among
lactating mothers with hospitalized premature infants.

Setting
BayCare Health System is a community based health care
system made up of 14 hospitals that serve the Tampa Bay, Saint
Petersburg and Clearwater areas. Morton Plant Mease (MPM)
Hospital is a 687-bed facility with over 25 specialty services
located in Clearwater, Florida. Of these specialty services,
obstetric services account for over 3,000 deliveries per year
with a 10 bed, semi-private room level II Neonatal Intensive
Care Unit (NICU). St. Joseph’s Women’s Hospital (SJWH) is the
largest birthing facility within the BayCare network. It is
located in Tampa, Florida and accounts for over 6,000 births
annually with 49 Level III private room infant beds and 15 Level
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II private room infant beds. Both facilities are fully staffed
with a neonatologist or nurse practitioners that tend to the
NICU 24 hours a day. Mothers with infants admitted to the NICU
at both facilities have high breastfeeding initiation rates
close to 95%. Sufficient lactation support is available to NICU
mothers at SJWH and MPM with daily lactation consultants,
adequate hospital grade breast pumps and highly skilled nursing
staff trained in lactation support. In addition to lactation
support, SSC is routinely practiced within the guidelines
outlined by the BayCare SSC evidence based clinical standards
and protocols. In addition, MPM and SJWH utilize the BayCare
network electronic medical record (EMR) that may be helpful for
the research team to verify demographic and outcome measures.

Participants
Twenty lactating mothers and their premature infants born
37 weeks and 0 days – 22 weeks and 0 days of gestational age
were enrolled in the study.

Inclusion Criteria
Postpartum lactating females that: 1) are 0 - 7 days
postpartum, 2)intend to breastfeed or breast pump, 3) initiate
breastmilk expression within 12-24 hours after birth, and 4)
have performed SSC with her neonate at least once since delivery
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were included in the study. In addition to this inclusion
criteria, participants were able to speak and read English or
Spanish and have access to a telephone with mode of
transportation to and from the hospital until infant discharge.
Neonatal infants born 37 weeks and 0 days – 22 weeks and 0 days
of gestational age admitted to the NICU were enrolled into the
study after parental consent.

Exclusion Criteria
Mothers with maternal diagnoses or behaviors
contraindicated in breastfeeding, polydrug use, human
immunodeficiency virus (HIV), galactosemia, active tuberculosis
(TB), radioactive isotopes, chemotherapy, or active herpes
lesions on the breast(2012) or taking medications that may
affect salivary oxytocin assay like antidepressants,
psychotropic or dopamine agonist/antagonist medications

were

excluded from the study. Premature infants unable to perform SSC
(e.g. umbilical intravenous lines, terminal conditions, surgical
emergencies and congenital anomalies) were also excluded from
the study.
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Measures
Demographic Data and Medical History
Standard socio-economic demographic and medical history
data (Appendix A) were collected at baseline in English or
Spanish by self-report and verified with the EMR for neonatal
and maternal subject information. A chart audit was completed to
update demographic or medical history information at all data
collection time points (baseline, session 1, and session 2).

Variables
Independent Variable (Skin to Skin Contact)
SSC frequency and duration was documented by each mother in
a daily tracking log (Appendix B). Metrics were recorded in
minutes per SSC session with start time, stop time, and daily 24
hour total minutes. Additional co-variants, such as infant
gestational age, weight, feeding method (bottle, tube feeding,
breastfeeding), and nutrition source (breastmilk, formula, donor
milk or mixed) and nipple stimulation (pumping or breastfeeding)
were also documented in the tracking log by self-report.

Dependent Variable Collection (Salivary Oxytocin)
Salivary samples were collected at 4 time points per
participant by the drool method (Appendix C) and handled with
the specimen handling procedure in Appendix H. Sample collection
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was timed for 5 minutes by participants at each time point and a
protease inhibitor (aprotinin) was immediately added prior to
centrifugation, aliquotted and frozen in a freezer located in
the hospital at -60°C. Frozen samples were batched once a month
and then transported to the College Of Nursing Biobehavioral
laboratory in a cooler and stored at −80°C. After specimens were
thawed and dried down, salivary samples were prepared for assay
utilizing the enzyme-linked immunosorbent assay (ELISA) kit
manufacture procedure (Enzo Life Sciences Product. Catalog
Number ADI-900-153). Each dried sample was reconstituted in
assay buffer to concentrate the sample and assayed in duplicate.
The assay protocol utilizes a polyclonal antibody to
competitively bind oxytocin prior to incubating specimens
overnight at 4°C. After incubation, excess reagents were washed
and the enzymatic reaction was stopped and read at 405nm
immediately. Oxytocin concentration was calculated by
immunoassay software utilizing a logistic curve fitting program.

Procedures
Approvals
Institutional Review Board (IRB) approvals from University
of South Florida and BayCare Health System at Morton Plan MeaseSaint Anthony Hospital and St Joseph’s Women’s Hospital was
obtained prior to enrolling participants.
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Consent, Recruitment and Screening
Twenty-five postpartum lactating mothers were screened for
inclusion criteria (Appendix D) by collaborating coinvestigators (neonatologist and advanced practice nurses) within
24-48 hours post-delivery and prior to maternal discharge from
the hospital. Mothers that met inclusion criteria (N = 20) were
approached by co-investigators to evaluate interest in
enrollment. Mothers who expressed interested in enrolling in the
study were referred to the Principal Investigator (PI) by coinvestigators or given a recruitment flyer (Appendix E) to
contact the PI directly. The PI provided additional information
at the patient bedside prior to obtaining informed consent.
Mothers were oriented to the study protocols and consent
document by the PI in a quiet and private area using clear and
simple language. Adequate time to read the informed consent
document was given to allow for all questions to be answered.
Comprehension of the research protocol and consent was ensured
by querying the individual in regards to salient talking points
in the checklist provided in Appendix G. After consent,
participants were supplied with data collection materials and
assessed for demographic and medical history data. A $20 gift
card and honorarium receipt (Appendix I) was offered for
participation of the study upon completion to reduce attrition
from the study.
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Data Collection Procedure
Data collection among participants included the following
intervals: baseline, session 1 and session 2. Baseline data
collection began on the day of consent where an overview of the
benefits of SSC and hospital protocol was provided concurrent
with critical study elements defined in the consent form. After
obtaining consent, participants were supplied with data
collection materials, maternal and infant demographic/medical
history questionnaire, instructions on SSC, breastmilk
expression and drool method procedures for salivary oxytocin
during session 1 and session 2. At the end of session 2 the PI
reconciled and compiled the participant’s tracking log data and
updated maternal and infant medical history information verbally
or via hospital EMR.

Skin to Skin Contact
Mothers were asked to self-report SSC data in their
tracking log immediately after consent for up to 7 days
depending upon neonatal discharge from the hospital. The PI
screened for missing data by verifying entries of SSC
frequency/duration and co-variant data after session 1 and
session 2 with the mother. Missing data was corrected by the
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mother or PI by the end of session 2. A summary of data
collection procedures has been provided in Table 3.

Salivary Oxytocin
Samples were collected at 4 time points for all lactating
mothers. Participants were asked to arrive at the NICU at 9:00
am each morning of saliva sample collection. Mothers were
instructed to eat breakfast from 7:00 – 8:30 am and not to eat,
brush, floss or use mouthwash one hour prior to collection.
Participants were also notified to avoid caffeine, alcohol, and
nicotine smoke and to report any extreme tooth decay or
gingivitis. Immediately prior to collecting salivary samples,
participants were asked to rinse their mouth with water to
remove any food particles. To avoid potential hormone variations
relative to diurnal rhythm, samples were collected no earlier
than 9:00 am. Salivary oxytocin has been found to be elevated
within 30 minutes post breast pumping/breastfeeding or during
pumping/breastfeeding (Rosemary et al., 2009). In keeping with
these parameters, basal salivary samples were collected prior
placing the neonate SSC at least 30 minutes post milk expression
or breastfeeding to avoid suckle induced oxytocin release.
Samples collected with any nipple stimulation or suckling during
SSC was documented on the daily tracking log and considered for
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recollection if feasible. Specimens collected under SSC
intervention were collected within the last 5-10 minutes of SSC
while the infant is still being held by the mother (i.e. 55-60
minute time point of SSC) due to oxytocin’s pulsatile nature and
short-half-life.

Data Analysis
Power analysis for this exploratory research was not
feasible because statistical data on basal oxytocin in
comparison to SSC has never been reported. MPM NICU census
estimates 20 premature infants were admitted per month with
approximately 50% eligible for SSC with a length of stay of
seven to fourteen days. Feasibly, these admission rates indicate
that 25 mother-infant dyads (5 per month) could be recruited
over a six to eight month study period with the anticipation
that a minimum of 20 ( 80 observations = 40 with no SSC and 40
post SSC) would continue through the study for the 7 day time
frame.

Preliminary Analysis
For testing Specific Aim 1: Explore the relationship
between oxytocin and SSC among lactating mothers with
hospitalized premature infants, the basal oxytocin measured by
saliva sample with and without SSC on each day was computed to
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form a new measure.

The two differences were used as the

repeated measures of the true difference variable. A mixed
effects model that fits the true difference variable in the
previous step as the dependent variable with other controlled
variables including frequency and duration of SSC as the
independent variables was determined by the lowest Akaike
information criteria (AIC).

Additional Analysis
Further analysis for Specific Aim 1 utilized paired sample
t test to compare within-session and within-subject data to
determine acute and sustained effects of SSC on basal oxytocin.
Acute effects were assessed by determining within-session
effects by analyzing the difference between the with and without
oxytocin measures per session 1-2. Sustained effects were
analyzed by the single measure within-subject data to determine
the difference between two time point changes in salivary
oxytocin (i.e. session 1 and session 2) over time per subject.

Limitations
Recruitment limitations secondary to the complexity of
consenting premature mothers due to environmental and emotional
stressors were avoided at time of consent with the inclusion of
language and mode of transportation. Additionally, while most
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mothers are discharged from the hospital within 2-3 days postdelivery, many return to visit their infants daily to administer
hands on care and promote bonding. Offering an honorarium to
participants also minimized enrollment limitations by reducing
attrition from the study.

Protection of Human Subjects
Human Subjects Involvement, Characteristics and Design
Twenty-five lactating mothers and their premature infant
were screened for eligibility for the study. Mothers and infants
with maternal diagnoses/behaviors contraindicated in
breastfeeding were excluded from the study as well as premature
infants unable to perform SSC. Collaborating neonatologists and
clinical nurses trained on the study protocol recruited
participants prior to meeting the PI. The PI made weekly contact
with mothers who consented to monitor compliance of SSC selfreport, assure accuracy of salivary sample collection and
encouraged continued participation of the study. Confidentiality
was maintained by removing identifying information, assigning
study identification numbers to all data and securing the code
in a locked cabinet. Sources of maternal demographic and medical
history data were abstracted from the medical record and
documented on case report forms (CRF). Saliva samples and CRFs
were only labeled with the subject number and only the PI could
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link the study subject with the sample. Data maintained
electronically was password protected.

Potential Risks
The risks of performing SSC and collecting salivary samples
were minimal. Before and after SSC, electrocardiogram and pulse
oximeter devices monitored neonatal heart rate, respirations and
oxygen saturation. On the occasion that the neonatal vital signs
range outside of normal parameters, i.e. bradycardia or oxygen
desaturation, will trigger alarms for the attending practitioner
or bedside nurse to respond and assess the situation.

Inclusion of Women and Minorities
Women were included in the study. Twenty mothers and their
premature infant born 37 weeks and 0 days – 22 weeks and 0 days
of gestational age were enrolled. Presumably, infants enrolled
in the study were of the same ethnicity as their mother.
Targeted distribution of subjects included mothers of all
ethnicities and infants of both gender types.
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Table 3. Data Collection Procedure Summary

Baseline

Time Frame

Data Collection

# saliva samples

Session 1

Session2

0-7 days post

0-3 days post

3 days post

delivery

consent

session 1

Informed

Saliva Sample

Saliva Sample

consent

SSC tracking

SSC tracking

Demographics

lod data

lod data

Medical History

verified and

verified and

transcribed

transcribed

Medical Hx

Medical Hx

update

update

0

2
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CHAPTER FOUR:
RESULTS

Restatement of the Problem and Study Aim
In the United States, prematurity remains one of the top
three leading causes of death annually. Exclusive human milk
feedings have been known to reduce infant mortality.
Unfortunately, mothers of premature infants are challenged with
multiple stressors that affect their ability to provide
exclusive human milk feedings to their infants. Compounding
effects of these stressors inhibit the secretion of oxytocin
hormone and affect the ejection reflex. A poor ejection reflex
perpetuates a cycle that negatively affects the amount of human
milk expelled from the mammary glands. This in turn leads to
altered human milk synthesis and insufficient human milk volume.
Mediating effects of skin to skin contact (SSC) between a mother
and her neonate is suspected to repair altered lactogenesis and
human milk volume but the true relationship between SSC and
basal oxytocin levels have yet to be determined.
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In this chapter results of the research design discussed in
chapter 3 aims to better understand the true relationship
between basal salivary oxytocin levels and SSC among lactating
mothers with hospitalized premature infants by answering the
following research questions:

1a. Does maternal basal salivary oxytocin differ across 7 days
in mothers before SSC?
1b. Does SSC frequency affect basal salivary oxytocin levels?
1c. Does SSC duration affect basal salivary oxytocin levels?

Data Collection Methods
Variables identified in the logic model (Figure1, Chapter
2) were measured under similar conditions by limiting inclusion
criteria to: 1) postpartum mothers of premature infants born 37
weeks and 0 days – 22 weeks and 0 days of gestational age, 2)
mothers that had given birth within 0 -7 days, 2) mothers that
intended to breastfeed/pump, 3) mothers that initiated breast
pumping within 12-24 hours after birth and 4) mothers that
implemented SSC with her neonate at least once since giving
birth. Those with maternal diagnoses or behaviors
contraindicated in breastfeeding, polydrug use, HIV,
galactosemia, active TB, radioactive isotopes, chemo therapy,
active herpes lesions on the breast or taking medications that
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may affect salivary oxytocin assay like antidepressants,
psychotropic or dopamine agonist/antagonist medications were
excluded from the study.

Sample
Early recruitment at Morton Plant Hospital initially met
recruitment goals of 5 per month until mid-recruitment time due
to a reduction in NICU census. To increase participant
eligibility, recruitment was sought at St. Joseph’s Women’s
Hospital after IRB approval. Ongoing recruitment continued for
an additional two months at both facilities and ended after nine
months of recruitment due to grant funding limitations. A total
of twenty-five postpartum lactating mothers were screened by
collaborating neonatologists and advanced practice nurses for
inclusion criteria at participating neonatal intensive care
units (NICU) within the BayCare Health System. Of the twentyfive recruits, one declined to participate because she felt
uncomfortable performing SSC with her neonate and four were
excluded because of limited transportation, polydrug use or
inability to meet inclusion criteria.

The remaining twenty that

met full inclusion criteria were approached by the PI and
consented to participate (N= 20 mother-infant dyads) in the
study. Demographic and social determinant information were
collected via self-report questionnaire at time of consent and
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summarized in Table 4. Additional physiologic and co-variant
characteristics discussed in the literature review and outlined
in the study logic model are included in Table 5 and Table 6.

Differences among Sample Characteristics
Differences in social determinant and physiologic factors
among sample participants were determined via one-way ANOVA
using SPSS software. Since maternal age has been known to
predict premature birth and early lactation failure (Avery,
Duckett, Dodgson, Savik, & Henly, 1998; Beta, Akolekar, Ventura,
Syngelaki, & Nicolaides, 2011; Furman, Minich, & Hack, 2002) the
sample size was categorized into two groups based on maternal
age. Group one (n=10) included post-partum mothers less than 31
years of age and Group two (n=10) included post-partum mothers
greater than 31 years of age. Social determinant factors were
dichotomized for race (1=white,0=black), insurance (1=private,
0=Medicaid), marital status (1=single,0 = married) and WIC
eligibility (1= yes, 0=no). There were no outliers, as assessed
by boxplot; data were normally distributed for each age group,
as assessed by Shapiro-Wilk test (p > .05); and there was
homogeneity of variances, as assessed by Levene's test of
homogeneity of variances (p = .781 and p =.932). Differences
between age group across marital status (F(1,18)= 0.184,p =
0.673), race (F(1,18) = 0.275,p = 0.660), and insurance (F(1,18)
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= 0.184, p = 0.673), were not significant. WIC eligibility was
the same across both age groups (p = 1.000).
Physiologic factor differences (Table 7) were also
determined via one-way ANOVA per age group. Mode of delivery was
dichotomized (1= vaginal delivery, 0 = cesarean delivery),
comorbidities were categorized by three levels (0 = none, 1 =
hypertension/preeclampsia, 2 = endocrine/thyroid disease), first
pregnancy status, or primigravida, was dichotomized (1=yes and 0
= no) and both gestational age (GA) and infant weight were
continuous raw score variables. Data based on these parameters
were normally distributed among both age groups for infant
weight, comorbidities and primigravida by Shapiro-Wilk test (p >
.05) with no outliers as assessed by boxplots. Mode of delivery
did have two extreme outliers identified via box plots for age
group one. Errors in data entry were assessed to determine
probable cause for outliers with no need for correction.
Homogeneity of variances for infant weight, comorbidities and
primigravida were also determined by Levene's test of
homogeneity of variances (p = 0.631, p =0.192, p = 0.865, and p
=.065). Mode of delivery and GA did not have homogeneous
variances (p =.001). Continued data analysis with ANOVA testing
was not performed with variables that had outliers or nonhomogeneous variance (mode of delivery and GA) due to the
violation of ANOVA assumptions. For the remaining variables that
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met the assumptions of ANOVA, no significant differences were
identified between age groups for comorbidities (F(2,17)=0.119,p
= 0.888), primigravida (F(1,18)= 0.275,p = 0.660)and infant
weight (F(1, 18)= 2.165, p = 0.158.
Dependent Variable Data Collection and Measurement
Maternal saliva samples (n= 76) were collected at 4 time
points during two 90-minute sessions at the bedside of the
neonate in the NICU. Due to early neonatal discharge for
participants 16 and 20 specimen sample sizes differ by two units
per session. Salivary samples were collected over 5 minutes by
the drool method (Appendix C) in the amount of 3-5 milliliters.
To maintain the integrity of the samples repeat freeze and thaw
times were avoided with careful specimen handling (Appendix I)
as recommended by the Enzo Life Sciences Product enzyme-linked
immunosorbent assay (ELISA) oxytocin kit manufacture procedure
(Catalog Number ADI-900-153). Immediately after collection ten
microliters of Aprotinin was added to each specimen, kept cold
on ice and transported to the laboratory for centrifugation X
1500 rpms for 10 minutes at 4 degrees centigrade. Specimens were
then aliquoted in 1 ml tubes and promptly frozen at negative 6070 degrees within one hour of collection. Frozen samples were
batched monthly and transported to the College Of Nursing

56

Biobehavioral laboratory in a cooler with dry ice to be stored
at −80°C until ready for assay.
When ready for assay specimens were prepared utilizing the
manual’s 14 step ELISA procedure with the exclusion of
extraction columns. In exchange for the use of extraction
columns, the kit manufacturer advised to follow the methodology
utilized by Feldman, Gordon, and Zagoory-Sharon (2010) where
thawed specimens were dried down via lyophylizer overnight and
reconstituted in enzyme immunoassay (EIA) buffer with a higher
concentration. Once reconstituted, specimens were assayed in
duplicate with paired standard samples and incubated overnight
at 4°C. After incubation all the wells were washed, emptied and
prepared for the second one hour incubation period after adding
p-nitrophenyl phosphate (pNpp) substrate solution to each well.
Post incubation the enzymatic reaction was stopped and the plate
was read at 405nm immediately. Oxytocin concentration in
picograms per milliliter (pg/ml) was calculated by the
immunoassay PRISM software utilizing a 4 parameter logistic
curve. Specimens with an intra-assay coefficient of variation
(CV) greater than 15 (n=7) were repeated, excluding participant
4 at time point 1 with a CV of 17 percent due to insufficient
quantity of specimen available.
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Dependent Variable Validity and Reliability
The study’s protocol for specimen handling and ELISA was
tested with two control samples within child-bearing age.
Control one (C1) was a 24 year old lactating post-partum female
and control two was a 36 year old non-lactating female. To
account for circadian rhythm and variation associated with day
and time both specimens were collected after 9am on the same
date and time. Results of both control samples (Table 8)
detected normal salivary OT concentration based on previous
research and provided reassurance that the study protocol for
handling and processing saliva specimens maintain the integrity
of the sample.
To determine if the OT ELISA kit was a good measure of OT,
assay validity and reliability were tested by the manufacturer’s
analysis of sensitivity, precision and cross reactivity. In the
product manual the manufacturer references the use of the
National Committee for Clinical Laboratory Standards evaluation
protocols and guidelines to test for sensitivity by determining
the average optical density bound for forty eight wells (M 0.67,
SD 0.03) compared to the average optical density for forty-eight
wells with standard number 7 (M .61, SD 0.02) with a detection
limit determined at 2 SD from the zero along the standard curve
that resulted in 15.0 pg/ml (ie.- standard 7 OT concentration).
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The manufacturer describes testing for intra-assay
precision with 20 replicates of three controls containing OT in
a single assay and inter-assay as using controls of varying OT
concentrations in 17 assays over several days. Results of the
intra-assay test detected OT concentration that ranged 39.9 363.7 pg/ml with a CV range of 10-13 percent and the inter-assay
tests resulted in OT concentrations that ranged 47-398 pg/ml
with a CV range of 11-21 percent.
Cross reactivity test results among 13 related compounds
were also included in the kit manual to be sure similar
molecular structures like OT did not interfere with accuracy of
OT measurement. For this test, the manual describes dissolving
each compound in assay buffer first and then serially diluting
each compound to concentrations of 10,000 pg/ml to 0.6 pg/ml
prior to being measured in the OT assay. Percent cross
reactivity for 11 compounds reached less than 0.02% with 2
compounds measuring close to 7%.

Preliminary and Exploratory Data Analysis
Dependent Variable
Maternal OT salivary samples (n= 76) were collected during
two sessions for a total of 4 time points over a 7 day time
frame. During session one (n = 20), time point one of salivary
OT was collected under basal conditions with no SSC and time
59

point two under SSC intervention with a mean of 50 minutes of
SSC duration (SD 15.80 minutes). During session two (n=18), time
point 3 of salivary OT was again taken under basal conditions
with a mean interval of 3 days (SD 1.20) between sessions. The
final repeated measure at time point 4 of salivary OT was
collected under SSC intervention with a mean of 54.70 minutes of
SSC duration (SD 13.20 minutes). Descriptive data analysis
performed via SPSS in Table 9 document the differences between
OT specimen sample size and OT concentration per time point with
further descriptive data for CV and time of collection in Table
10 for the entire sample (n=76).
Other differences among OT concentrations (Table 9) based
on conditions at time of collection (neonatal day of life (DOL),
time, and interval) are presented in Table 11 and 12. Figures 2
and 3 provide a preview of the relationship OT concentrations
(n=76) per time of day with higher values in the afternoon near
1400 military time and a continuous increase in value over time
per DOL. To determine the significance of these conditions at
time of collection on OT concentration a one-way ANOVA was
performed to compare time of collection (1 = AM, 2 = PM),
interval between repeated measure category (1 = < 3 days, 2 = 3
days, 3 = > 3 days) and day of life (DOL) at 3 levels (1 = < 5
days, 2 = 5-7 days, 3 = > 7 days). Through boxplots, no
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extraneous outliers were detected more than 2 box-lengths from
the edge of the box. Homogeneity of variance was satisfied with
Levene’s test (p = > .05) for all variables. The differences
between OT and DOL (F(2, 73) = 0.3.420,p =0.038) was significant
whereas time of collection(F(1,74) = 2.907,p = 0.092) and
interval between sessions were not. Follow up data analysis via
Post HOC Tukey test among the DOL > 7 days group (M = 310 pg/ml,
SD = 160 pg/ml) compared to the DOL < 5 days group (M = 219
pg/ml, SD = 105 pg/ml), was statistically significant (p = .040)
with a mean increase of 92 pg/ml, 95% CI [-10.2, 162].
To remove pooled sample bias for time and DOL among samples
collected under basal conditions (n=36), the sum of saliva
specimens collected with no SSC (time point 1 and time point 3)
were combined to signify basal OT (M 250 pg/ml, SD 148 pg/ml).
Results of the scatter plots (Figures 4 and 5) replicate peak
concentrations of basal OT near 1400 military time and support
an increase in value of OT over time per DOL. Despite these
results, the difference between basal OT and DOL are not
significant (F(2, 36) = 1.860, p = 0.171).
Independent Variable
Daily SSC was collected via self-report diary data over a 7
day time frame. Metrics were recorded in minutes per SSC session
with start time, stop time, and daily 24 hour total minutes.
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Missing data was corrected by the mother or verified by
electronic medical records by the end of the 7th day study
period. Descriptive statistics via SPSS (Table 13) separates SSC
frequency by number of SSC sessions (M = 4 sessions, SD = 1
session) measured over the participant’s enrollment period and
the average amount of SSC measured in minutes per day (M 68
minutes per day, SD 27 minutes per day); whereas SSC duration (M
291 minutes, SD 165 minutes) accounts for the total amount of
SSC measured in minutes over the participant’s enrollment
period.
While the study enrollment period was targeted for 7 days,
the number of days of diary data reported by participants ranged
from 2-6 days and is the reason for inflated SD measurements. To
account for this variability, Table 14 shows the adjusted SSC
frequency (M 4 sessions, SD 0.1 sessions; M 68 minutes per day,
SD 6 minutes per day) and duration (M 291 total minutes, SD 6
total minutes) variables clustered within the number of days of
diary data category (1 = less than 5 days, 2 = 5 days and 3 =
more than 5 days).

Exposure of the Independent Variable on the Dependent Variable
At time of consent, SSC exposure was controlled by
requiring implementation of SSC at least once prior to study
enrollment. Post consent, SSC diary data suggest a gradual
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increase in SSC exposure over time and time point (Figure 6 and
7). Descriptive statistics in Table 15 display differences among
the sample and mean SSC exposure prior to each OT time point
collection (M = 141 minutes, SD 81; M 133 minutes, SD 96; M 235,
SD 140; M 300, SD 149). Table 16 includes descriptive statistics
that compare differences among SSC exposure and OT
concentrations per time point. Preliminary data analyses predict
how the dependent variable and independent variable are
associated via line of fit scatter plot projections in Figures
8-12.

Acute Effects of the Independent Variable
Oxytocin pre and post scores for session 1 (time point 1
vs. time point 2) and session 2 (time point 3 vs. time point 4)
were measured per interval of repeated measures via paired ttest to determine acute effects of SSC on OT. Concentrations for
both sessions were normally distributed with no outliers. Pre
and post paired t test of OT at Session 1 were not significant
(Table 17). However, pre and post paired t- test scores for
session 2 (n = 10) were significant with a moderate effect size
(t(9) = -71.30, p = 0.047, d = 0.7). Session 2 paired means were
also correlated with r = 0.935 and p = <0.001 (Table 17 and 18).
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Sustained Effects of the Independent Variable
Mean scores for time point 1 (n=20) and time point 4 (n=18)
were measured to determine if OT had sustained effects of SSC
over time. No outliers in the data set were identified as
assessed by inspection of a boxplot for values greater than 1.5
box-lengths from the edge of the box per time point. Mean scores
for time point 1 (M 236 pg/ml, SD 105 pg/ml) and time point 4 (M
269 pg/ml, SD 170 pg/ml) were correlated (r= 0.483, p = .042)
but paired t-test was non-significant (t(17) = -1.708, p =
0.106). Analysis per interval data counter these findings and
indicate that paired t-test results for sustained effect time
points collected with a 3 day interval are significant with a
small effect size (t(9) = 2.425, p = 0.038, d =.15).

Statistical Analysis for Specific Aim 1
Question 1
To answer question 1 of the specific aim: “Does maternal
basal salivary oxytocin differ across 7 days in mothers before
SSC?” differences between basal OT concentrations were
determined via scatter plots, Pearson correlations and pairedsamples t-test to compare the mean difference between paired
observations of basal OT at time point 1 and time point 3.
Paired OT samples with a CV < 15 were included for analysis
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(n=17 pairs). Figure 13 scatter plot suggests that OT
concentrations collected under basal conditions are positively
associated indicating an increase in means of basal OT from 234
pg/ml (SD 107 pg/ml) at time point 1 to 257 pg/ml (SD 125 pg/ml)
at time point 3. Pearson correlations (n=17) confirm that the
relationship between both time points are positively associated,
but the measures are not correlated (r=.449, p = .071). Pairedsamples t-test for basal OT at time point 1 and time point 3 are
also non-significant (t(16) = .756, p = .461).
Question 2
To answer question 2 of the specific aim: “Does SSC
frequency affect basal salivary oxytocin levels?” Initial data
analysis procedures discussed in the original proposal proposed
the use of a difference variable (i.e. – OT timepoint1-OT
timepoint2) as the dependent variable in a mixed multilevel
model analysis, however the use of the difference variable would
be an inappropriate measure of SSC frequency or duration on OT
because it focuses on the acute affect OT rather than the
variance explained of the dependent variable under basal
conditions.

To remove this bias from the entire OT sample

(n=76), the dependent variable was redefined as the group mean
of OT at time point 1 and time point 3 (basal OT) to only
include OT levels corresponding with no SSC intervention (n=20).
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Plot diagrams (Figure 14) describing basal oxytocin and SSC
frequency measured in mean minutes per day where categorized as
low = < 50 minutes of SSC per day, medium = 50-75 minutes,
moderate = 75-85 minutes and high = > 85 minutes of SSC per day.
Preliminary analyses with scatter plot interpolation identify
peak basal oxytocin under moderate SSC exposure. Elevated mean
concentrations of basal OT (Table 18) for moderate measures of
SSC frequency per day (M 572.92 pg/ml, SD 451 pg/ml) support
this prediction. To determine if these measures of SSC frequency
significantly affect basal OT concentrations, a 1 level fixed
effect and 4 level random effects multilevel model analysis was
structured with an AIC of 226.85. The omnibus test for the model
was significant (F(1, 16) = 101, p = <0.001) indicating that
average basal OT concentrations of the sample population differ.
Fixed effects from the intercept was also significant t(16) =
6.389, p = < 0.001) indicating that the average basal OT
concentration was 480 pg/ml with a standard error of 75 pg/ml.
While coefficient estimates per each SSC frequency parameter
were not significant (p = .814, p = .867, p = .589) coefficient
estimates for moderate SSC exposure (92.66 pg/ml, standard error
167 pg/ml) indicate that basal OT concentrations exposed to 7585 minutes of SSC per day are 92 pg/ml higher than the group
mean (480 pg/ml).

The variance component explained by the model

at level 1 representing SSC frequency within-groups was
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significant (p = < 0.005). An interclass correlation (ICC) among
SSC frequency groups was not calculated because the variance
estimate was zero.
To determine if a different measure of SSC frequency better
fit the data, SSC frequency per mean number of sessions (Table
14) compared to basal OT concentrations was analyzed in a 1
level fixed effect and 3 level random effects multilevel model
analysis with an AIC of 238.45. The omnibus test for the model
was significant (F(1, 17) = 110.99, p = <0.001) indicating that
average basal OT concentrations of the sample population differ.
Fixed effects from the intercept was also significant t(17) =
5.955,

p

=

<

0.001)

indicating

that

the

average

basal

OT

concentration was 539 pg/ml with a standard error of 90 pg/ml.
Coefficient estimates per each SSC frequency parameter were not
significant

(p

=

.313,

p

=

.685).

The

variance

component

explained by the model at level 1 representing SSC frequency per
number of sessions within-groups was significant (p = < 0.004).
An interclass correlation (ICC) among SSC frequency groups was
not calculated because the variance estimate was zero.
While both models resulted in a significant omnibus test
indicating mean basal OT differ across all SSC frequency groups,
model 1 was the best fitting model that explained the effects
and variance within and between SSC frequency groups because it
had the lower AIC (Table 20).
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Question 3
To answer question 1b of the specific aim: “Does SSC
duration affect basal salivary oxytocin levels?”, sustained
effects of SSC duration in minutes per enrollment period on OT
collected under basal conditions were determined via scatter
plots, descriptive data and a mixed effects multilevel model
analysis. Preliminary data analysis via scattered plots in
Figure 15 and 16 and Table 21 suggest that basal OT levels
increase as SSC duration increases over time.
To determine if sustained effects of SSC duration affect
basal OT, SSC total duration in minutes clustered within number
of days of diary data discussed in Table 14 were structured
within a 1 level fixed effect and a 3 level random effects
model. The omnibus test for the model was significant (f(1, 17)
= 109.11, p = < 0.001) indicating that the average basal OT
among the sample population differed. Fixed effects from the
intercept was also significant (t(17) = 6.867, p = < 0.001)
indicating that the average basal OT was 491.70 pg/ml with a
standard error of 71.60 pg/ml. Coefficients of SSC group 1 (M
281 total minutes, SD 80 total minutes) indicate that basal OT
concentrations are 48 mg/ml higher than average mean basal OT
(491 pg/ml). The variance component at level 1 representing SSC
duration between and within-groups was significant (p = 0.004).
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An interclass correlation (ICC) among SSC frequency groups was
not calculated because the variance estimate was zero.

Additional Data Analysis
Relationship between OT and Covariants
Preliminary analyses of co-variants were determined via
descriptive statistics, scatter plots and Pearson correlations
in Tables 22 and 23 and Figures 17, 18 and 19. Results show that
basal OT correlates with OT collected under SSC intervention (r
= .575, p =.008) indicating that as basal OT increases OT
concentrations under SSC intervention continue to increase as
well. Similarly, HM volume correlates with SSC frequency and
duration (r = .750, p = < .001; r = .585, p = .007), indicating
that as SSC increases HM volume continues to increase over time.
Beyond this relationship, HM volume does not directly predict or
significantly affect OT collected with or without SSC.

Predictors of Salivary OT under SSC Intervention
Since inclusion criteria required the implementation of SSC
prior OT collection, all basal OT measures were influenced by
sustained effects of SSC. The use of regression analysis
determined how much variation of OT with SSC intervention can be
explained by covariant independent variables in the logic model.
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In the first regression analysis, the proportion of variance
explained by SSC frequency and duration variables (SSC number of
episode per day, SSC mean minutes per day and SSC total duration
in minutes) on OT with SSC (time point 2 and time point 4) was
45% with a moderate to large effect size (adjusted R2 = .53).The
assumptions of linearity, independence of errors,
homoscedasticity, unusual points and normality of residuals were
all met. SSC frequency and duration variables were not
significant predictors of OT with SSC (F(1, 3) = 1.353, p
=.293). However, Pearson correlations indicate that OT with SSC
and SSC duration have a significant positive correlation
(r=.041, p = < .05). Unstandardized coefficients indicate that
for every 1 unit SSC total minutes increases when all other
independent variables are held constant, OT with SSC increases
1.225 units.

Unstandardized coefficients are in Table 23.

To determine if the influence of OT with SSC would be
affected by other covariates identified in the logic model of
the study design, a second regression analysis was performed
with the inclusion of the following co-variants clustered by
number of days of diary data: 1) total human milk volume per
milliliters (HM total), 2) nipple stimulation at time of
collection, and 3) feeding method (where 1= nasogastric tube, 2
= oral feeding, 3 = breastfeeding with nasogastric tube, 4 =
exclusive breastfeeding), birth weight and gestational age.
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Proportion of variance explained by all five variables was 68%
with a low effect size (adjusted R2 = .271). The assumptions of
linearity, independence of errors, homoscedasticity, unusual
points and normality of residuals were met via scattered plots,
casewise P-P plot, review of all standardized residual cases
less than ±3 SD for outliers and Durbin-Watson statistic of
1.555. Human milk volume, nipple stimulation, method of feeding,
birth weight and gestational age were not significant predictors
of OT with SSC (F(1, 5) = 2.409, p =.089). Pearson correlations
indicate that OT with SSC, birth weight, and gestational age
have a significant positive correlation (r =.005, r = .021).
Unstandardized coefficients are in Table 24.

Summary and Conclusion
Results of this research were conducted on a homogenous
sample with no significant deviations among demographic and
biologic factors (race, age, insurance, marital status infant
weight, comorbidities and gravidity). Similarly, salivary OT was
well controlled for variability associated with time and
interval collected with a non-significant F test.
Over time OT was found to increase per day of life (F(2,
73) = 0.420, p = 0.038) with a mean increase of 92 pg/ml for the
entire sample (n=76). Via scatter plots mean basal OT also
increased per DOL and time point (M 234 pg/ml, SD 26 pg/ml time
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point 1; M 257 pg/ml, SD 30 pg/ml time point 3) but the
relationship between basal OT, DOL and time point was not
significant (F(2, 36) = 1.860, p = 0.171; t(16) = .756, p =
.461). In comparison to SSC exposure, basal OT was found to have
a meaningful amount of dependence on SSC frequency (t(16) =
6.389, p = < 0.001) and SSC duration (t(17) = 6.867, p = <
0.001) with a high level of variance explained by within groups
(p = .005, p = .004). Coefficient estimates for moderate SSC
frequency exposure indicate that basal OT concentrations exposed
to 75-85 minutes of SSC per day are 92 pg/ml higher than the
group mean of 480 pg/ml.

Through regression analysis OT

measured with SSC also correlated with SSC duration (r=.041, p =
< .05). Unstandardized coefficients indicate that for every 1
unit SSC total minutes increases when all other independent
variables are held constant, OT with SSC increases 1.225 units.
HM volume correlates with SSC frequency and duration (r = .750,
p = < .001; r = .585, p = .007), indicating that as SSC
increases; HM volume continues to increase over time. Beyond
this relationship, HM volume does not directly predict or
significantly affect OT collected with or without SSC.
Implications of these findings on the true relationship
between basal salivary oxytocin levels and SSC among lactating
mothers with hospitalized premature infants will be presented in
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Chapter 5 including clinical significance and recommendations
for further course of study.
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Table 4. Sample Demographic and Social Determinant Factors
ID

AGE

RACE

Ethnicity

Insurance

Marital
Status

WIC
Eligible

1

19

Black

Non-Hispanic

Medicaid

Single

Yes

2

31

White

Non-Hispanic

Medicaid

Single

Yes

3

23

Black

Non-Hispanic

Medicaid

Single

Yes

4

19

White

Hispanic

Self-pay

Single

Yes

5

27

White

Non-Hispanic

Medicaid

Married

Yes

6

30

White

Non-Hispanic

Private

Married

No

7

31

White

Non-Hispanic

Private

Married

No

8

35

White

Non-Hispanic

Private

Married

No

9

28

White

Non-Hispanic

Private

Married

No

10

19

Black

Hispanic

Medicaid

Single

Yes

11

35

White

Hispanic

Self-pay

Single

Yes

12

30

White

Hispanic

Medicaid

Single

Yes

13

33

White

Non-Hispanic

Private

Married

No

14

30

White

Non-Hispanic

Private

Married

No

15

38

White

Non-Hispanic

Private

Married

No

16

34

White

Non-Hispanic

Medicaid

Single

Yes

17

31

White

Non-Hispanic

Private

Married

No

18

33

Black

Non-Hispanic

Private

Single

Yes

19

27

White

Hispanic

Private

Single

Yes

20

40

Black

Non-Hispanic

Medicaid

Single

Yes

Note. Social economic status classified via insurance. WIC = Women Infant and Children
Government Nutrition Program
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Table 5. Sample Physiologic Factors
ID

Age

Gestational
Age

Gravida

Para

Mode of
Delivery

Comorbidities

Medications

1

19

29

2

2

Vaginal

-

-

2

31

34

2

1

Vaginal

Hypertension

PNV

3

23

34

1

1

Vaginal

Thyroid disease

-

4

19

34

2

2

Vaginal

-

-

5

27

34

6

5

Vaginal

-

-

6

30

32

1

2

Vaginal

Hypertension

PNV

7

31

33

1

1

Vaginal

-

-

8

35

33

2

2

Vaginal

-

PNV

9

28

33

1

1

Vaginal

-

Analgesic

10

19

34

1

2

Cesarean

-

Iron supplement

11

35

32

1

4

Cesarean

-

Analgesic

12

30

34

2

1

Cesarean

-

Analgesic

13

33

34

2

2

Vaginal

-

-

14

30

34

2

2

Vaginal

-

PNV

15

38

35

1

4

Cesarean

Thyroid disease

-

16

34

36

3

2

Cesarean

-

PNV

17

31

34

2

2

Vaginal

-

-

18

33

35

4

1

Cesarean

Hypertension

PNV

19

27

31

2

1

Cesarean

Hypertension

PNV

20

40

37

2

2

Cesarean

-

Iron supplement
& Analgesic

Note. Gravida = number of pregnancias, Para= number of living children, PNV = prenatal
vitamin
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Table 6. Sample Co-Variant Factors

ID

GA

Infant
Weight

1

29

3lbs 1oz

2

34

4lbs 0oz

3

34

3lbs 14oz

4

34

3lbs12oz

5

34

4lbs 15

6

32

4lbs 12oz

7

33

3lbs 2oz

8

33

4lbs 0oz

9

33

3lbs 14oz

10

34

3lbs 6oz

11

32

5lbs 0oz

12

34

5lbs 7oz

13

34

6lbs 7oz

14

34

4lbs 9oz

15

35

6lbs 3oz

16

36

6lbs 10oz

17

34

5lbs 12oz

18

35

4lbs 4oz

19

31

2lbs 10oz

20

37

5lbs 11oz

Infant
weight in
grams

Feeding
Method

Nutrition Source

Nipple
Stimulation
via
breastfeeding

1389

NG

MBM

No

1814

NG

Mixed

No

1758

NG

Mixed

No

1701

Mixed

Mixed

Yes

2239

NG

DM/MBM

Yes

2155

Sham

MBM

Yes

1417

NG

MBM

No

1814

Mixed

Mixed

Yes

1758

Mixed

Mixed

Yes

1503

Mixed

Mixed

No

2268

Mixed

MBM

No

2466

NG

Mixed

No

2920

BF

Mixed

Yes

2070

Mixed

Mixed

Yes

2807

Mixed

MBM

Yes

3005

Mixed

Mixed

Yes

2608

Mixed

Mixed

Yes

1928

Mixed

Mixed

No

1190

NG

Mixed

No

2580

PO

Mixed

No

Note. GA= Gestational age. Feeding method categories (NG) Nasogastric tube (PO),= Oral
or Per os, Sham (breastfeeding and NG),(BF) = Exclusive breastfeeding, (NG/PO/BF)=
Mixed. Nutrition source categories MBM = maternal breastmilk, DM = donor milk, mixed =
formula with MBM or DM

76

Table 7. Descriptive Statistics for Normally Distributed
Physiologic Factors by Age Group
Variable Clustered by

N

Minimum

Maximum

Mean

SD

Age group
Age group > 31 years
GA (weeks)

10

32

37

34.40

1.430

Weight (grams)

10

1417

3005

2239

532.64

Primigravida

10

Comorbidities

10

Age group < 31 years
GA (weeks)

10

29

34

32.80

1.69

Weight (grams)

10

1190.00

2807.00

1899.40

500.82

Primigravida

10

Comorbidities

10

Note. GA = gestational age in weeks, Primagravida= 1 = yes, 0 = no, weight = infant
birth weight in grams, comorbidities = 0 = none, 1 = hypertension/preeclampsia, 2 =
endocrine/thyroid disease
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Table 8. Salivary Oxytocin Controls for Handling and ELISA
Procedure

ID

Days Post
Delivery

Condition

OT (pg/ml)

C1

7

Lactating

63.39

C2

N/A

Non-lactating

168.15

Note. C1 = control one, C2 = control 2
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CV

3%
2%

Table 9.Salivary Oxytocin Descriptive Statistics per Time Point
Time point

N

Minimum

Maximum

Mean

SD

(pg/ml)

(pg/ml)

OT1

20

113.44

441.77

240.67

96.03

OT2

20

63.66

471.79

203.70

108.12

OT3

18

36.03

524.64

262.56

124.21

OT4

18

65.03

704.02

296.77

170.32

Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC,
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC
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Table 10. Salivary Oxytocin Descriptive Statistics for
Coefficient of Variation and Time Collected
Variable

N

Minimum

Maximum

Mean

SD

CV

76

0%

17%

5%

4%

Time

76

910.00

1830.00

1213.61

228 minutes

Note. CV = inter-assay coefficient of variation, Time = military time
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Table 11. Salivary Oxytocin Concentration per Interval between
Repeated Measures at Time of Collection

Interval

< 3days

3 days

> 3 days

Time Point

N

Minimum

Maximum

Mean

SD

(pg/ml)

(pg/ml)

OT1

5

184.00

429.00

259.40

98.43

OT2

5

93.00

342.00

173.40

105.79

OT3

3

207.00

524.00

350.00

160.75

OT4

3

125.00

380.00

279.66

135.90

OT1

10

119.00

441.00

243.10

104.77

OT2

10

79.00

471.00

226.80

119.73

OT3

10

130.00

450.00

267.60

110.10

OT4

10

74.00

704.00

338.90

192.51

OT1

5

113.00

343.00

200.00

100.14

OT2

4

64.00

335.00

192.75

110.90

OT3

4

36.00

239.00

159.75

87.14

OT4

5

65.00

409.00

222.20

138.40

Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC,
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC.
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Table 12. Salivary Oxytocin Concentration and Time of Collection
Variables per Time Point

Time Point

Variable

N

OT1

OT pg/ml

20

113.44

441.77

240.69

96.04

Time

20

915.00

1800.00

1212.0

237.73

DOL days

20

2.00

8.00

4.4500

1.57

OT pg/ml

20

63.66

471.79

203.76

108.09

Time

20

1025.00

1830.00

1307.2

223.92

DOL days

20

2.00

8.00

4.4500

1.57

OT pg/ml

18

36.03

524.64

262.68

124.13

Time

18

910.00

1725.00

1111.6

211.69

DOL days

18

5.00

11.00

7.4444

1.78

OT pg/ml

18

65.03

704.02

296.86

170.28

Time

18

1010.00

1827.00

1213.2

211.19

DOL days

18

5.00

11.00

7.4444

1.78

OT2

OT3

OT4

Minimum

Maximum

Mean

SD

Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC,
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC, OT =
oxytocin, Time = military time, DOL = days of life.
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Oxytocin pg/ml

Time of Collection in Military Time

Figure 2. Trend of Oxytocin Concentration per Time of Day
(N=76)
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Oxytocin pg/ml

Neonatal Day of Life (DOL) at Time of Maternal
Saliva Collection

Figure 3. Trend of Oxytocin Concentration per Neonatal Day of
Life (N=76)
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Basal Oxytocin pg/ml

Time of Collection in Military Time

Figure 4. Trend of Basal Oxytocin Concentration per Time of
Day (n=37)
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Basal Oxytocin pg/ml

Neonatal Day of Life (DOL) at Time of Maternal
Saliva Collection

Figure 5. Trend of Basal Oxytocin Concentration per Neonatal Day
of Life (n=37)
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Table 13. Skin to Skin Frequency and Duration Descriptive
Statistics

Variable

N

Minimum

Maximum

Mean

SD

SSCTmin

20

30.00

630.00

291.20

163.54

SSCF

20

1.00

7.00

4.25

1.77

SSCfmeanperday

20

17.00

117.00

67.90

26.85

Note. SSCTmin = total amount of SSC measured in minutes over the participant’s
enrollment period. SSCF= number of SSC sessions measured over the participant’s
enrollment period SSCfmeanperday = average amount of SSC measured in minutes per day.
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Table 14. Skin to Skin Contact Frequency and Duration
Descriptive Statistics Clustered within Number of Days of Diary
Data
Variable

N

Minimum

Maximum

Mean

SD

SSCTmin

20

281.80

294.50

291.20

5.57

SSCF

20

4.14

4.40

4.25

.10

SSCfmeanperday

20

63.75

78.80

67.90

6.48

Note. SSCTmin = total amount of SSC measured in minutes over the participant’s
enrollment period. SSCF= number of SSC sessions measured over the participant’s
enrollment period SSCfmeanperday = average amount of SSC measured in minutes per day.
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Skin to Skin Contact in Minutes

Neonatal Day of Life (DOL) at Time of Maternal
Saliva Collection

Figure 6. Skin to Skin Exposure by Neonatal Day of Life
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Skin to Skin Contact in Minutes

Time Point of Oxytocin Collection

Figure 7. Scatter Plot of Skin to Skin Exposure per Time
Point
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Table 15. Descriptive Statistics for Skin to Skin Exposure prior
Oxytocin Time Point Collection

Time point

N

Minimum

Maximum

Mean

SD

(minutes)

(minutes)

OT1

11

33.00

300.00

141.27

81.23

OT2

20

30.00

390.00

133.05

95.67

OT3

18

50.00

510.00

235.11

139.77

OT4

18

105.00

570.00

300.78

149.23

Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC,
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC.
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Table 16. Descriptive Statistics for Skin to Skin Exposure and
Oxytocin Concentration per Time Point Collection
Time Point
OT1
OT2
OT3
OT4

Variable

N

Minimum

Maximum

Mean

SD

SSC minutes

11

33.00

300.00

141.27

81.22

OT pg/ml

20

113.44

441.77

240.69

96.04

SSC minutes

20

30.00

390.00

133.05

95.66

OT pg/ml

20

63.66

471.79

203.76

108.09

SSC minutes

18

50.00

510.00

235.11

139.77

OT pg/ml

18

36.03

524.64

262.68

124.13

SSC minutes

18

60.00

570.00

286.61

159.54

OT pg/ml

18

65.03

704.02

296.86

170.28

Note. OT1= basal OT at time point 1 with no SSC , OT2= OT at time point 2 with SCC,
OT3 = basal OT at time point 3 with no SSC, OT4 = OT at time point 4 with SSC.
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Skin to Skin Contact in Minutes

Oxytocin pg/ml

Figure 8. Relationship between Skin to Skin Exposure and
Oxytocin Concentration (n=76)
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Skin to Skin Contact in Minutes

Basal Oxytocin pg/ml at Time Point 1

Figure 9. Basal Oxytocin Concentration and Skin to Skin
Exposure at Time Point 1 (n=11)
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Skin to Skin Contact in Minutes

Oxytocin pg/ml at Time Point 2

Figure 10. Skin to Skin Exposure and Oxytocin Concentration
at Time Point 2 (n=20)
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Skin to Skin Contact in Minutes

Basal Oxytocin pg/ml at Time Point 3

Figure 11. Basal Oxytocin Concentration and Skin to Skin
Exposure at Time Point 3 (n=18)
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Skin to Skin Contact in Minutes

Oxytocin pg/ml at Time Point 4

Figure 12. Skin to Skin Exposure and Oxytocin Concentration
at Time Point 4 (n=18)

97

Basal Oxytocin pg/ml at Time Point 3

Basal Oxytocin pg/ml at Time Point 1

Figure 13. Relationship between Basal Oxytocin Repeated Measures
(n=20)
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Table 17. Acute Effects of Skin to Skin on Oxytocin by Interval

Interval

Session

N

Correlation

Sig

Days between
sessions

3days

4days

Session 1

10

.463

.178

Session 2

10

.935

.00*

Session 1

4

-.639

.361

Session 2

4

-.528

.472

Note.* p <.05, session 1= oxytocin collected at time point 1 vs time point 2, session
2= oxytocin collected at time point 3 vs time point 4
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Table 18. Acute Effects of Skin to Skin on Oxytocin Paired TTest
Interval

Session

Mean

SD

T test

(pg/ml)

(pg/ml)

(+/-)

df

Sig

1day

Session 1

88.000

103.23

1.205

1

.441

2days

Session 1

206.00

172.53

1.659

1

.340

Session 2

10.500

101.12

.147

1

.907

Session 1

16.300

117.06

.440

9

.670

Session 2

-71.300

97.75

2.307

9

.047*

Session 1

-8.7500

198.20

.088

3

.935

Session 2

-75.000

215.58

.696

3

.537

3days

4days

Note.* p <.05, session 1= oxytocin collected at time point 1 vs time point 2, session
2= oxytocin collected at time point 3 vs time point 4
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Basal Oxytocin pg/ml
Basal Oxytocin pg/ml

Skin to Skin Frequency by Category

Skin to Skin Frequency by Category

Figure 14. Plots Describing Basal Oxytocin and Skin to Skin
Contact Frequency
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Table 19. Descriptive Statistics for Basal Oxytocin per Skin to
Skin Frequency

SSC Frequency
Category

N

Mean
(pg/ml)

SD
(pg/ml)

Coefficient
of Variation

low

5

451.26

198.64

44.0%

medium

5

459.59

209.56

45.6%

moderate

2

572.92

451.15

78.7%

high

8

480.26

162.20

33.8%

Total

20

477.11

197.95

41.5%

Note. low = < 50 minutes of SSC per day, medium = 50-75 minutes, moderate = 75-85 minutes and
high = > 85 minutes of SSC per day
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Table 20. Basal Oxytocin and Skin to Skin Contact Frequency
Fixed effects

SSC
Frequency

Coefficient

Std.

(pg/ml)

Error

Parameter

df

t

Sig.

95% Confidence
Interval

(pg/ml)

Lower

Upper

Bound

Bound

Intercept

480.26

75.06

16

6.398

.000*

321.14

639.39

low

-28.10

121.03

16

-.240

.814

-285.58

227.58

medium

-20.67

121.03

16

-.171

.867

-277.25

235.91

92.66

167.84

16

.552

.589

-263.15

448.48

.

.

.

.

.

moderate
high

-

-

Note.* p <.05, low = < 50 minutes of SSC per day, medium = 50-75 minutes, moderate
= 75-85 minutes and high = > 85 minutes of SSC per day
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Table 21. Basal Oxytocin and Skin to Skin Contact Duration
Descriptive Statistics

Variable

N

Basal OT(pg/ml)

20

195.57

891.93

477.11

197.95

SSC Total
Duration in
minutes

20

30.00

630.00

291.20

163.53

Minimum

104

Maximum

Mean

SD

Figure 15. Skin to Skin Duration per Participant
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Basal Oxytocin pg/ml

Skin to Skin Duration in Minutes

Figure 16. Relationship between Skin to Skin Duration and Basal
Oxytocin
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Table 22. Covariant Data Descriptive Statistics

N

Minimum

Maximum

Mean

SD

OT with SSC (pg/ml)

20

92.54

1001.10

473.166

261.44

HM total in ml

20

101.00

5978.00

1440.75

1517.93

Nipple

20

0

1

0

0

20

1

5

3

1.90

stimulation
Feeding method

Note. OT with SSC = salivary oxytocin collected at time point 2 and 4) HM total = total human
milk volume per milliliters (ml), nipple stimulation (1= yes, 0= no at time of collection),
feeding method (1= nasogastric tube, 2= oral feeding, 3= breastfeeding with nasogastric tube, 4 =
exclusive breastfeeding)
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Basal Oxytocin pg/ml

Total Human Milk Volume in
Milliliters

Figure 17. Scatter Plot of Basal OT and Human Milk Volume
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Basal Oxytocin pg/ml

Total Human Milk Volume in
Milliliters

Figure 18. Scatter Plot of OT with SSC and Human Milk Volume
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Oxytocin with SSC pg/ml

Basal Oxytocin pg/ml

Figure 19. Scatter Plot of Basal OT and OT with SSC
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Table 23. Covariant Data Correlations

OTnoSSC
OTnoSSC

Pearson

SSCTmin

SSCF

HMtotal

.091

-.026

-.223

.008

.702

.913

.344

20

20

20

20

20

.575**

1

.399

.228

.141

.081

.335

.554

1

OTwithSSC
**

.575

Correlation
Sig. (2-tailed)
N

OTwithSSC

Pearson
Correlation
Sig. (2-tailed)
N

SSCTmin

Pearson

.008
20

20

20

20

20

.091

.399

1

.842**

.585**

.702

.081

.000

.007

20

20

20

20

20

-.026

.228

.842**

1

.750**

.913

.335

.000

20

20

20

20

20

-.223

.141

.585**

.750**

1

.344

.554

.007

.000

20

20

20

20

Correlation
Sig. (2-tailed)
N

SSCF

Pearson
Correlation
Sig. (2-tailed)
N

HM total

Pearson

.000

Correlation
Sig. (2-tailed)
N

20

Note.* p <.05. OTnoSSC = salivary oxytocin at time point 1 and 3; OTwithSSC = salivary
oxytocin collected at time point 2 and 4; SSCTmin = total amount of SSC measured in
minutes over the participant’s enrollment period. SSCF= number of SSC sessions
measured over the participant’s enrollment period. HM total = total human milk volume
per milliliters (ml), nipple stimulation (1= yes, 0= no at time of collection),
feeding method (1= nasogastric tube, 2= oral feeding, 3= breastfeeding with
nasogastric tube, 4 = exclusive breastfeeding)
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Table 24. Unstandardized Coefficients for Skin to Skin Frequency
and Duration

Variable

Unstandardized Coefficients

t

Sig.

Partial
Correlation

Std. Error
(Constant)
SSCTmin
SSCF
SSCfmeanperday

398.298

180.465

2.207

.042

1.225

.750

1.633

.122

.378

-52.980

61.307

-.864

.400

-1.93

-.835

3.349

-.249

.806

.422

Note. SSCTmin = total amount of SSC measured in minutes over the participant’s
enrollment period. SSCF= number of SSC sessions measured over the participant’s
enrollment period
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Table 25. Covariant Unstandardized Coefficients on OT with SSC
Varaibles Clustered by
diarydatagroups

Unstandardized

t

Sig.

Coefficients

Partial
Correlations

B

Std. Error

-106.19

220.92

-.481

.638

-.02

.04

-.600

.558

69.79

153.04

.456

.655

35.64

30.95

1.151

.269

.29

Weight group

325.13

144.97

2.243

.042*

.51

GA group

121.03

85.05

1.423

.177

.36

(Constant)
HM total
Nipple
stimulation
Feeding method

Note.* p <.05
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-.16
.12

CHAPTER 5:
CONCLUSIONS

Methods and Procedures
This one-group, repeated measures design involved daily SSC
via self-report diary data and maternal salivary OT with and
without SSC at 4 time points over a 7 day time frame.
Major Findings
Mean levels of OT under basal conditions increased over
time with a mean concentration of 234 pg/ml (SD 108 pg/ml) at
time point 1 and mean concentration of

257 pg/ml (SD 125 pg/ml)

at time point 3. Pearson correlations confirmed that the
relationship between basal OT time points were positively
associated, but the two were not significantly correlated
(r=.449, p = .071) and were also non-significant via paired sample
t-test (t (16) = .756, p= .461. Through mixed effects multilevel
model data analysis, basal OT levels were found to have a
meaningful amount of dependence on SSC frequency (t(16) = 6.389,
p = < 0.001) and SSC duration (t(17) = 6.867, p = < 0.001) with
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coefficient estimates that indicate that basal OT concentrations
in women exposed to moderate levels of SSC (75-85 minutes of SSC
per day) were 92 pg/ml higher than the group mean of 480 pg/ml.
In addition, basal levels of OT were found to correlate with OT
collected under SSC intervention (r= .575, p =.008) indicating
that as basal OT increases OT under SSC intervention continues
to increase as well. Similarly, HM volume correlated with SSC
frequency and duration (r = .750, p = < .001; r = .585, p =
.007), indicating that as SSC increases HM volume continues to
increase over time. Beyond this relationship HM volume did not
directly predict or significantly affect OT collected with or
without SSC.
Discussion
Results of this research suggest that lactating mothers
with premature infants sustain positive effects of SSC that
increase basal OT secretion over time. Prior to this research
salivary OT had never been measured during SSC in order to
explore the relationship between basal OT and SSC among
lactating mothers with hospitalized premature infants. These
findings are unique and narrow the gap in the literature by
adding a better understanding of the physiology of
galactokinesis by satisfying three research questions. In
relation to question 1a, maternal basal salivary oxytocin did
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differ across 7 days in mothers before SSC but the relationship
was non-significant. For questions 1b and 1c, SSC frequency and
duration did positively affected basal salivary oxytocin levels
over the enrollment period.
Exposure of term infants to SSC intervention for 25 to 120
minutes after birth, with or without early suckling, positively
influences mother-infant interaction at 1 year of age compared
to standard care that separates mother and infant at birth
(Bystrova et al., 2009). For premature mother-infant dyads,
separation at birth is common and often triggers episodes of
maternal sadness, depression and anxiety (Carvalho, Martinez, &
Linhares, 2008). Positive effects of OT secretion elicit
maternal “feel good” responses that improve mood, reduce
symptoms of stress, depression and anxiety while promoting
social attachment (Pratt et al., 2015; Samuel et al., 2015; Tops
et al., 2013; Uvnas-Moberg, 1996; Weisman, Zagoory-Sharon, &
Feldman, 2013). SSC has also been known to reduce maternal
stress and depression in NICU environments (Flacking, Thomson,
Ekenberg, Lowegren, & Wallin, 2013; Holditch-Davis et al.,
2014). In this research, maternal benefits of OT secretion and
SSC intervention are likely to manifest with routine SSC
exposure (75-85 minutes per day) when OT levels are markedly
higher and encouraged continuously (24 hours/7 days a week) in
high tech neonatal environments(Nyqvist et al., 2010).
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Findings of this dissertation research also provide new
insight on the relationship of SSC on oxytocin and human milk
volume. Due to lack of lactogenic hormone measurement in
previous research (Hill et al., 1999; Hurst, 1997), gaps in the
literature presumed that SSC yielded more HM volume because SSC
increased oxytocin secretion thus allowing the expulsion of HM
from the mammary gland. However, evidence from this research
showed that OT did not correlate with HM volume and suggests
that SSC serves as a mediator for HM volume in response to an
increase in OT secretion. Recent findings by Acuna-Muga et al.
(2014) published that mean human milk volumes were significantly
higher during (107.7 mL) and after SSC (117.7 mL) compared to
milk volumes obtained at the beside of the incubator (96.9 mL).
Ongoing research aims to determine if milk expression conducted
in proximity to the infant, particularly prior and during SSC is
associated with higher milk volume via secondary data analysis.
Limitations
Measurement Error
Large standard deviations among mean OT concentrations
raise areas of concern regarding the accuracy, reliability and
stability of OT measurement. McCullough, Churchland, and Mendez
(2013) agreed that plasma OT measurement lacked reliability
depending upon methodology and technique and suggested that an
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accurate, specific, and readily available method for measuring
OT be standardized in the field.

Likewise, Horvat-Gordon,

Granger, Schwartz, Nelson, and Kivlighan (2005) reported that
meaningful oxytocin levels may not be detected in saliva assay.
However, more recent studies have successfully measured salivary
oxytocin with a modified concentration or extraction procedure
technique mentioned (Carter et al., 2007; Feldman, Gordon, &
Zagoory-Sharon, 2011; Grewen, Davenport, & Light, 2010; WhiteTraut et al., 2009). Results of this research contribute to
salivary OT technique recommended by the manufacturer. While
noticeable discrepancies were noted per basal OT time point with
a standard deviation of 26 for time point 1 and standard
deviation of 30 for time point 3, assay wells that measured
standard controls of OT were within normal limits for each EIA
kit assayed. Since OT is labile and pulsatile in nature (Ueda,
Yokoyama, Irahara, & Aono, 1994) with a 5 minute half-life, such
factors may contribute to discrepancies noticed among OT
salivary concentration. Although important, these factors are
difficult to control and require more rigorous research beyond
the scope of this study.
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Sample Size
Power analysis to determine sample size was not attainable
because statistical data (ie. - sample means, alpha and effect
size) on basal oxytocin in comparison to SSC had never been
published. Feasible sample size was determined by NICU census
data and budget restraints for a total of twenty participants
yielding a sum of 76 observations. However, depending upon the
test performed for data analysis, smaller sample sizes were
required to answer each research question.
For this research data analysis for a sample size of 17,
paired sample t-test resulted in a non-significant t test. In
hypothesis testing, a non-significant t test would indicate
rejecting the null hypothesis where basal OT at time point 1 is
not equal to basal OT at time point 3. Rejecting the null would
then indicate that the alternative hypothesis would be true
indicating that basal OT at time point 1 and time point 3 are
the same. To determine the probability of rejecting the null
hypothesis in error, both the effect size and power are
considered given a certain sample size. Via G*Power 3.1.9.2
(Faul, Erdfelder, Lang, & Buchner, 2007) the paired samples t
test where OT at time point 1 mean was 234 pg/ml (SD 108 pg/ml)
and OT at time point 3 was 257 pg/ml (SD 125 pg/ml) calculated
an effect size of d=0.2 with a power level of 20%. Implications
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of a small effect size and low power level suggest that results
of the study were under powered for determining differences in
basal OT over time and increases the probability of committing a
type II (false-negative) error. To reduce the likelihood of type
II error, findings of this research should be replicated in
future studies with a larger sample size. An increase in sample
size reduces the likelihood of results differing from the
population, resulting in a significant t-test indicating that
basal OT significantly differs over time (Banerjee, Chitnis,
Jadhav, Bhawalkar, & Chaudhury, 2009).

Design
Inclusion of a comparison or control group was also not
feasible due to budget limitations of this research. Future
studies comparing basal OT concentrations among mother-infant
dyads that do not perform SSC would offer an unbiased estimate
of basal OT concentrations over time. These findings would
better explain trends of OT during the day, over time and by
neonatal day of life. In addition, the exclusion of maternal
stress also limits clear interpretations of SSC on OT and human
milk volume. Psychological and physiological measures of stress
are expected to decrease over time at 2, 4, and 6 weeks
postpartum with no significant differences in cortisol and
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oxytocin among mothers with non-nursing infants less than 1500
grams (Chatterton et al., 2000). Measuring acute and sustained
stress responses in the NICU will validate the use of SSC as a
means to deregulated maternal stress responses to increase OT
and possibly HM volume.
Conclusions
Preliminary findings of this study have a high level of
significance for nursing science because it provides insight on
the relationship between SSC and oxytocin hormone. This new
understanding adds to the importance of continued SSC
intervention to promote sustained effects of SSC on the
physiology of galactokinesis and maternal mental health that
improve mood and attachment behaviors. Preliminary data analyses
also suggest that SSC mediates human milk volume in response to
an increase in OT over time. Immunologic benefits of breast
milk, consumed by the premature infant via exclusive human milk
feedings, offers a significant contribution to neonatal health
care outcomes by reducing the incidences of neonatal
complications associated with premature delivery, such as
sepsis, NEC, and death.
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Recommendations
Continued research comparing maternal salivary cortisol and
OT with and without SSC will determine if SSC physiologically
deregulates maternal stressors that influence OT secretion and
HM volume. Presumably, OT increases under moderate levels of SSC
exposure and SSC exposure positively correlates with human milk
volume. Dose responses of SSC frequency, duration relative to
human milk volume and oxytocin release are pending on-going data
analysis.

Funding for this research was provided by the Southern Nurse’s
Research Society Dissertation Grant Award.
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Appendix A: Demographics and Medical Information Questionnaire

Participant ID: ____________ Date of Birth: ___/____/_____ Age ____
Ethnicity
Hispanic or Latino
Race:
White
Asian

Black /African American
American Indian/Alaska Native
Pacific Islander
Other__________________________

Marital Status:
Insurance:

Not Hispanic or Latino

Single

Private

Married
Medicaid

Divorced

Widowed

Self Pay

Pregnancy and Birth Information:
Date of Delivery: ___/____/_____ Time of Birth: _______
Type of delivery:

Vaginal

Cesarean

Gestational age at delivery: ______ weeks
How many pregnancies have you had? ____ How many living children? ___
Did you take any medications during your pregnancy? Yes
No
If yes please name the medications _______________________________
____________________________________________________________
Are you still taking these medications? Yes
No
If yes please name which medications_______________________________
____________________________________________________________
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Did you experience any prenatal or delivery complications (for example - high
blood pressure, preterm labor, severe illness, etc)? Yes
No
If yes please explain ___________________________________________
____________________________________________________________
Do you have any extreme tooth decay or gingivitis? Yes

No

Infant Information:
Sex of baby

Male

Female

Baby’s Birth Weight ________ lbs _______ oz (or) _________ gms
Why is your baby receiving care in the NICU?
___________________________________________________________
____________________________________________________________
____________________________________________________________
____________________________________________________________
Will your baby be receiving benefits form WIC? Yes

No

Have you breastfed your baby or pumped your milk since giving birth to your
baby? Yes
No
If yes what date & time? Date: ___/____/_____ Time: ____:_____ am/pm
Have you initiated skin-to-skin contact or kangaroo care since giving birth to your
baby? Yes
No
If yes when? Date: ___/____/_____ Time: ____:_____ am/pm
Did you feel comfortable holding your baby skin-to-skin? Yes
No
If no, please explain____________________________________________
Please provide any further information you would like to share about your
experience.
__________________________________________________________________
__________________________________________________________________
__________________________________________________________________
______________________________________________
Thank you for your time in completing this questionnaire.
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Appendix B: Tracking Log Instructions

After enrollment into the study please begin to track activities you perform related
to skin-to-skin, saliva collection and infant feedings. Below is an example to
follow:
Tracking Log Day 1: 2 / 12 / 14
Activity

Start Time

End Time

Feeding Type

Amount
(ml/min)

Minutes of SSC

BP

6:00 am

6:20 am

PM

10 ml

-

SSC

8:00 am

9:35 am

-

-

95 minutes

BF

10:00 am

10:15am

BF

15 minutes

-

B

10:30 am

10:45 am

DM

30 ml

-

S

9:00 am

9:05 am

-

-

0

95 minutes

Totals:
Activity Legend:
SSC – Skin-to-Skin Contact
BF – Breastfeed
BP – Breast pump
S – Saliva Collection
B – Bottle Feeding
* - nipple stimulation during SSC
Feeding Legend:
BF - Breastfed
PM – Pumped milk
DM – Donor milk
F – Formula
TB – Tube feeding
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Appendix C: Instructions for Drool Method Saliva Collection

Supplies to be given the day of collection:
2 Collection tubes (2ml Cryovials)
Cup of ice
Collection instructions:
1. On the day of saliva collection arrive at the NICU at 9am.
2. If upon arrival your baby is hungry and needs to breastfeed, nurse your baby
or pump. Wait 30 minutes after the feeding prior to saliva collection.
3. When ready for saliva collection, place both cryo vials in a cup of ice..
4. Next, rinse your mouth with water and spit it out in a sink or cup for
disposal. Mark the time of disposal in your tracking log.
5. Over the next 5 minutes spit out all of the saliva that collects in your mouth
into the collection tube without coughing or clearing your throat. Mark the
time you finish on your tracking log.
6. Place the cap on the collection tube and place it back in the cup of ice.
7. The PI will immediately label the tube with the collection date and time.and
transport the specimen to the laboratory for processing.
8. Place your baby skin-to-skin (try to avoid any nipple stimulation,
breastfeeding or pumping during skin-to-skin). If nipple stimulation does
occur during sample collections merely indicate it on your tracking form
with a star. These samples may need to be recollected.
9. Right before removing your baby in skin-to-skin contact (at 55 or 60
minutes of SSC) repeat steps 3-8 for the second saliva sample
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Appendix D: Recruitment Screening

Inclusion Criteria Screening: (no to any will be excluded)
1. Mother is 0-7 days Postpartum

Yes

2. Intends to breastfeed or breast pump

No
Yes

No

3. Initiated breastmilk expression within 12-24 hours after birth
4. Performed SSC with her neonate once since delivery
5. Speaks and reads English or Spanish
6. Access to a telephone

Yes

Yes

Yes

Yes

No

Yes

No

No

No

No

7. Has a mode of transportation to and from the hospital

8. Neonate born 37 – 22 weeks gestation & admitted to NICU

Yes

No

Exclusion Criteria Screening: (yes to any will be excluded)
1. Mother with maternal diagnoses/behaviors contraindicated in breastfeeding
(polydrug use, HIV, galactosemia, active TB, radioactive isotopes, chemo therapy, active
herpes lesions on the breast)

Yes

No

2. Taking medications contraindicated in salivary oxytocin assay (antipsychotic
medications)

Yes

No

3. Premature infants unable to perform SSC (umbilical lines, terminal conditions,
surgical emergencies, congenital anomalies)

Eligible for study

Yes

Consented to participate?
Date: ___/____/_____

Yes

No

No – place in PI box and text 813-469-3129
Yes

No

Participant ID: ________
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Appendix E: Recruitment Flyer
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Appendix G: Check List and Participant Instructions

Meet with the Principal Investigator _____/______/_____
Complete Consent Form _____/______/_____
Complete Demographic Questionnaire_____/______/_____
Receive Participant Instructions & Supplies _____/______/_____
Collect and Store Saliva Samples (within 0-7 days after delivery and 3 days later)
Day 1_____/______/_____

before SSC

after SSC

Day 2_____/______/_____

before SSC

after SSC

Complete Daily Tracking Log
Day 1

Day 2

Day 3

Day 4

Day 5

Day 6

Day 7

Submit Tracking Log, Forms and Samples to
Principal Investigator by:
_____/______/_____
Receive your $20.00 Gift Card to Baby’s R Us_____/______/_____
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Instructions for Mothers Performing Skin-to-Skin Care
Skin-to-skin contact is a safe practice that involves placing your naked baby on
your bare chest. Premature babies benefit from skin-to-skin care because it
increases their oxygen saturation, calms the baby, and regulates their heart rate,
breathing and temperature. The hospital supports skin-to-skin care and routinely
promotes when performed within their hospital guidelines.

To perform skin-to-skin:
1. First consult your baby’s nurse to see if it is safe to position your baby skinto-skin.
2. When safe, prepare for skin-to-skin position by find a chair or recliner with
pillows and footstool if available.
3. Wear an open-front shirt or gown to allow direct skin-to-skin contact.
4. Dress your newborn in only a diaper (a hat may be worn as well).
5. Allow the nurse to switch the incubator temperature control from servocontrol to air temperature to prevent incubator cooling while newborn is
being held.
6. Remove your baby from the crib or isolate and place your baby chest to
chest on your bare skin with your baby’s head in chin-tilt position.
7. Hold your baby securely as you recline into a 45 degree angle.
8. Wrap your gown or garment around the newborn and place a cover or
blanket over your chest and the newborn.
9. After five minutes if newborn’s feels too warm or temperature is greater than
99.0 degrees F remove the cover blanket.
10. Hold your newborn as long as desired (preferably a minimum of 1 hour) if
newborn remains stable.
11. Attempt to perform routine skin-to-skin contact when able.
12. Record each time you perform skin-to-skin with your baby in your tracking
log.
13. After skin-to-skin, dress your baby and place them back in his/her crib or
isolate
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Instructions for Mothers Pumping in the NICU
A hospital grade breast pump is preferred to help you build a good milk supply for
your baby. Single and double pump setups are available. Double-pump setups will
allow you to pump both breasts at the same time, but are not required.
After you deliver ask a nurse to provide you with a hospital grade breast pump for
your use during your hospital stay if you do not already have one. You should also
ask for plastic storage bottles and lids to collect your milk in at each pump session.
These storage bottles are for single use only and easily attach to the hospital pumps
for your convenience.
Each time you pump keep a daily record of the following information:
 the date of each session,
 start and end time of each pumping session,
 amount of milk pumped each session, preferably in millimeters (ml)
 daily 24 hour total of the amount of milk expressed.
This will help you be more certain that you are producing an adequate milk supply
for your baby.
When to pump
It is important for you to begin to pump your breast within four to six hours after
delivery, or as soon as you are physically able, especially if you are unable to
breastfeed your baby right away. This, along with continued frequent pumping,
will help stimulate your breast to produce milk and encourage adequate milk
production. The best time to pump is the same time you expect to feed your baby,
at least every 2-3 hours. This usually averages out to be 8-10 times a day.

Pumping Instructions
1. Wipe down the pump and wash your hands prior each pumping session.
2. Attach a clean setup with storage bottles to the pump (each bottle should only
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3.
4.
5.

6.
7.

collect expressed milk from one single pumping session.)
Place yourself in a comfortable position
Set the pump on minimum pumping force to begin, adjusting strength as
needed.
Pump breast for approximately 10-15 minutes. Remember this is just a rule of
thumb. Mothers should concentrate more on their own milk flow and are
encourage to pump at least two minutes after your milk flow stops to
completely empty the breast.
When finished pumping, take the breast pump setup apart and wash all parts in
luke- warm soapy water, rinse, air dry and store until next use.
Sterilize the pump accessories, excluding the tubing, by boiling them for 15
minutes or putting them through the dishwasher once a day. Microwaveable
sterilization bags may also be used as well.

Labeling Your Milk
Use a waterproof pen to label each bottle with your baby’s name and the date &
time of collection. If the hospital provides preprinted labels please use them but be
sure to verify that the name on the label is your baby’s each time you place a label
on a bottle you just expressed.
Storing Your Milk
Unless there is a medical reason, you can save your breast milk to be used to feed
your baby until he/she is ready to eat. During your hospital stay, properly label the
provided storage bottles and deliver the breast milk to the NICU immediately after
pumping to be placed in the refrigerator or freezer. Hospital freezer-storage
containers for long term use are usually available, but may be limited to one
container per baby. Any additional milk unable to be stored in the freezer container
should be stored at home.
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Appendix H: Salivary Oxytocin Assay Specimen Handling Procedure
1. Wear gloves and prepare supplies for collection.
2. Assist patient collect 3 -5 ml of saliva via drool method for 5 minutes.
3. Immediately place saliva sample in a cup of ice and add 10 microliters (UL) of Aprotinin
(PI) to 3 - 5 ml of saliva and transport on ice to the laboratory.
4. Spin saliva samples in centrifuge at 4 x 1000 rpms for 10 minutes at 4 degrees C.
5. Label 3 1.5 cryovials (clean tube) according to the labeling guidelines below with
permanent marker and fill each vial with 1ml of supernatant.
6. Freeze immediately at -70 degrees C and store in freezer box located in the
Microbiology Section of the laboratory within 30-60 minutes of collection.
7. Bach samples once per month and transport to the CON laboratory via dry ice.
8. Store samples in CON freezer at -80 degrees C until ready for Assay.

Specimen labeling guidelines:
001 – Participant ID
XX/XX – Date
0900 – time in military time
#1-4 – time point of collection
Session 1
#1 No SSC
#2 With SSC
Session 2
#3 No SSC
#4 With SSC
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Appendix I: Honorarium Receipt
Study: Skin to Skin Contact and Basal Salivary Oxytocin among
Lactating Mothers of Premature Infants
PI: Jessica M Gordon, MS, ARNP, CPNP-PC, CLC
Funded By: Southern Nurses’ Research Society Dissertation Award
BayCareIRB # - 2014.001
USF IRB # - 00017904
Participant reimbursement for time:
You will be reimbursed for the time you are providing in order
to complete your participation. A one-time receipt of a $20 gift
card will be provided.
I, ________________________________________,(print name)
agree to this reimbursement for participation.
I confirm that I have completed my participation in the study
and a $20 gift card payment has been provided to me as
reimbursement for my time. I understand that payment will only
be received one-time and the amount received will be equal to
the amount outlined on this form.

____________________________________

___________________________

(print name)

(date of birth)

____________________________________

___________________________

(signature)

(date)

_______________________________________________________________________
(street address)

_______________________________________________________________________
(city)

(state)

(zip code)

___________________________________

___________________________

(witness signature)

(date)
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Appendix J: Institutional Review Board Letters
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